UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the quarterly period ended September 30, 2022March 31, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the transition period from ___________ to __________

 

Commission File Number: 1-11398

 

CPI AEROSTRUCTURES, INC.

(Exact name of registrant as specified in its charter)

 

New York11-2520310
(State or other jurisdiction(IRS Employer Identification Number)
of incorporation or organization) 

 

91 Heartland Blvd., Edgewood, NY11717
(Address of principal executive offices)(Zip code)

 

(631) 586-5200

(Registrant’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which
registered
Common stock, $0.001 par value per shareCVUNYSE American

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    No  

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer  ☐Accelerated filer  ☐
Non-accelerated filer  ☒Smaller reporting company 
Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of November 18, 2022,May 11, 2023, the registrant had 12,383,42712,566,784 shares of common stock, $.001 par value, outstanding.

 

 

 

 

 

INDEX

 

Page No.Part I - Financial Information

Part I - Financial Information3
Item 1 – Consolidated Financial Statements (Unaudited)3
 
Condensed Consolidated Balance Sheets as of September 30, 2022March 31, 2023 (Unaudited) and December 31, 202120223
 
Condensed Consolidated Statements of Operations for the Three and Nine Months ended September 30,March 31, 2023 and 2022 and 2021 (Unaudited)4
 
Condensed Consolidated Statements of Shareholders’ DeficitEquity (Deficit) for the NineThree Months ended September 30,March 31, 2023 and 2022 (Unaudited) and 2021 (Unaudited)5
 
Condensed Consolidated Statements of Cash Flows for the NineThree Months ended September 30,March 31, 2023 and 2022 (Unaudited) and 2021 (Unaudited)6
 
Notes to Condensed Consolidated Financial Statements (Unaudited)7
 
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations1417
 
Item 3 – Quantitative and Qualitative Disclosures About Market Risk2022
 
Item 4 – Controls and Procedures2022
 
Part II - Other Information21
 
Item 1 – Legal Proceedings2124
 
Item 1A – Risk Factors2124
 
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds2124
 
Item 3 – Defaults Upon Senior Securities2124
 
Item 4 – Mine Safety Disclosures2124
 
Item 5 – Other Information2124
 
Item 6 – Exhibits2125
 
Signatures2226
 
Exhibits

Part I - Financial Information

 

Item 1 – Consolidated Financial Statements

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 March 31,    
       2023
(Unaudited)
  

December 31,

2022

 
 September 30,
2022
(Unaudited)
  December 31,
2021
      
ASSETS                
Current Assets:                
Cash $4,627,379  $6,308,866  $3,997,924  $3,847,225 
Accounts receivable, net  8,400,967   4,967,714   5,483,915   4,857,772 
Insurance recovery receivable  3,600,000   2,850,000   3,600,000   3,600,000 
Contract assets  24,157,141   24,459,339   30,362,951   27,384,540 
Inventory  3,108,241   4,028,925   2,334,567   2,493,069 
Refundable income taxes  42,335   40,000   40,000   40,000 
Prepaid expenses and other current assets  617,188   625,075   969,116   975,830 
Total current assets  44,553,251   43,279,919 
Total Current Assets  46,788,473   43,198,436 
                
Operating lease right-of-use assets  6,736,441   7,796,768   6,071,158   6,526,627 
Property and equipment, net  1,250,304   1,646,863   1,051,536   1,124,556 
Intangibles, net  31,250   125,000 
Deferred tax asset  6,374,470   6,574,463 
Goodwill  1,784,254   1,784,254   1,784,254   1,784,254 
Other assets  282,299   372,741   227,243   238,744 
Total assets $54,637,799  $55,005,545 
Total Assets $62,297,134  $59,447,080 
                
LIABILITIES AND SHAREHOLDERS’ DEFICIT        
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Current Liabilities:                
Accounts payable $12,768,638  $10,429,018  $10,812,974  $8,029,996 
Accrued expenses  4,564,515   6,102,587   5,779,242   7,344,590 
Litigation settlement obligation  3,600,000   3,003,259   3,600,000   3,600,000 
Contract liabilities  5,041,818   5,122,766   7,493,821   6,001,726 
Loss reserve  635,406   1,495,714   464,044   576,549 
Current portion of line of credit  1,920,000   1,200,000 
Current portion of long-term debt  2,591,928   3,365,181   1,097,841   1,719,766 
Operating lease liabilities  1,728,707   1,580,453 
Operating lease liabilities, current  1,872,484   1,817,811 
Income tax payable  3,750   5,165   11,396   11,396 
Total current liabilities  30,934,762   31,104,143 
Total Current Liabilities  33,051,802   30,301,834 
                
Line of credit  21,000,000   21,250,000   19,080,000   19,800,000 
Long-term operating lease liabilities  5,345,919   6,445,728   4,597,328   5,077,235 
Long-term debt, net of current portion  100,375   1,540,747   48,746   70,981 
Total liabilities  57,381,056   60,340,618 
Total Liabilities  56,777,876   55,250,050 
                
Shareholders’ Deficit:        
Common stock - $.001 par value; authorized 50,000,000 shares, 12,325,360 and 12,335,683 shares, respectively, issued and outstanding  12,325   12,336 
Shareholders’ Equity:        
Common stock - $.001 par value; authorized 50,000,000 shares, 12,526,042 and 12,506,795 shares, respectively, issued and outstanding  12,526   12,507 
Additional paid-in capital  73,082,112   72,833,742   73,528,353   73,189,449 
Accumulated deficit  (75,837,694)  (78,181,151)  (68,021,621)  (69,004,926)
Total Shareholders’ Deficit  (2,743,257)  (5,335,073)
Total Liabilities and Shareholders’ Deficit $54,637,799  $55,005,545 
Total Shareholders’ Equity  5,519,258   4,197,030 
Total Liabilities and Shareholders’ Equity $62,297,134  $59,447,080 

 

See Notes to Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

             
  

For the Three Months Ended 

September 30, 

  For the Nine Months Ended
September 30,
 
  2022  2021  2022  2021 
Revenue $20,196,913  $23,898,748  $59,257,416  $77,018,684 
Cost of sales  14,869,100   20,246,764   46,835,304   64,850,010 
Gross profit  5,327,813   3,651,984   12,422,112   12,168,674 
                 
Selling, general and administrative expenses  2,744,265   2,765,849   8,579,314   8,834,343 
Income from operations  2,583,548   886,135   3,842,798   3,334,331 
Other income     4,795,000      4,795,000 
Interest expense  (721,046)  (252,506)  (1,488,091)  (840,680)
Income before provision for income taxes  1,862,502   5,428,629   2,354,707   7,288,651 
                 
Provision for income taxes  3,750   3,374   11,250   7,702 
Net income $1,858,752  $5,425,255  $2,343,457  $7,280,949 
                 
Income per common share – basic $0.15  $0.44  $0.19  $0.60 
                 
Income per common share – diluted $0.15  $0.44  $0.19  $0.60 
                 
Shares used in computing loss per common share:                
Basic  12,301,752   12,286,712   12,362,960   12,153,838 
Diluted  12,349,283   12,320,588   12,410,491   12,187,714 

See Notes toCondensed Consolidated Financial Statements


CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ DEFICITOPERATIONS (UNAUDITED)

 

                
  Common
Stock
Shares
  Common
Stock
Amount
  Additional
Paid-in
Capital
  Accumulated
Deficit
  Total
Shareholders’
Deficit
 
Balance at January 1, 2021  11,951,271  $11,951  $72,005,841  $(85,001,524) $(12,983,732)
Net Income           1,232,543   1,232,543 
Stock-based compensation expense  33,881   34   343,693      343,727 
Balance at March 31, 2021  11,985,152   11,985   72,349,534   (83,768,981)  (11,407,462)
Net Income           623,151   623,151 
Common stock forfeited  (41,199)  (42)        (42)
Stock-based compensation expense  323,977   325   224,773      225,098 
Balance at June 30, 2021  12,267,930  $12,268  $72,574,307  $(83,145,830) $(10,559,255)
Net Income           5,425,255   5,425,255 
Stock-based compensation expense  33,881   34   154,615      154,649 
Balance at September 30, 2021  12,301,811  $12,302  $72,728,922  $(77,720,575) $(4,979,351)
                     
Balance at January 1, 2022  12,335,683  $12,336  $72,833,742  $(78,181,151)  (5,335,073)
Net Loss           (32,931)  (32,931)
Stock-based compensation expense  47,527   47   25,835      25,882 
Balance at March 31, 2022  12,383,210  $12,383  $72,859,577  $(78,214,082) $(5,342,122)
Net Income           517,636   517,636 
Stock-based compensation expense  66,117   66   137,432      137,498 
Balance at June 30, 2022  12,449,327  $12,449  $72,997,009  $(77,696,446) $(4,686,988)
Net Income           1,858,752   1,858,752 
Common stock forfeited  (171,495)  (171)        (171)
Stock-based compensation expense  47,527   47   85,103      85,150 
Balance at September 30, 2022  12,325,359  $12,325  $73,082,112  $(75,837,694) $(2,743,257)
                     

See Notes to Consolidated Financial Statements


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

       
  For the Nine Months Ended
September 30,
 
  2022  2021 
Cash flows from operating activities:        
Net income $2,343,457  $7,280,949 
Adjustments to reconcile net income to net cash used in operating activities:        
Depreciation and amortization  515,626   796,888 
Amortization of debt issuance cost  90,442   28,107 
Cash expended less than (in excess) of rent expense  108,772   (73,005)
Stock-based compensation  248,359   723,432 
Bad debt expense  3,189   127,413 
Forgiveness of PPP loan     (4,795,000)
Changes in operating assets and liabilities:        
Increase in accounts receivable  (3,436,442)  (3,709,001)
(Decrease) increase in contract assets  302,198   (3,030,953)
Decrease in inventory  920,684   1,406,360 
Increase in prepaid expenses and other assets  7,887   (111,731)
Increase in refundable income taxes  (2,335)   
Increase (decrease) in accounts payable and accrued expenses  801,548   (488,087)
Decrease in contract liabilities  (80,948)  891,915 
Increase in insurance receivable  (750,000)  (2,850,000)
Increase in settlement of litigation obligation  596,741   3,206,133 
(Decrease) increase in income taxes payable  (1,415)  469 
Decrease in loss reserve  (860,308)  (717,222)
Net cash provided by (used in) operating activities  807,455   (1,313,333)
         
Cash flows from investing activities:        
Purchase of property and equipment  (25,317)  (19,305)
Net cash used in investing activities  (25,317)  (19,305)
         
Cash flows from financing activities:        
Payments on long-term debt  (2,463,625)  (1,851,633)
Proceeds from line of credit     261,315 
Net cash used in financing activities  (2,463,625)  (1,590,318)
         
Net decrease in cash  (1,681,487)  (2,922,956)
Cash at beginning of period  6,308,866   6,033,537 
Cash at end of period $4,627,379  $3,110,581 
         
Supplemental disclosures of cash flow information:        
Cash paid during the period for:        
Interest $1,096,800  $609,485 
Income taxes $17,146  $7,233 
       
  For the Three Months Ended March 31, 
  2023  2022 
Revenue $22,016,668  $20,135,097 
Cost of sales  17,354,152   16,700,488 
Gross profit  4,662,516   3,434,609 
         
Selling, general and administrative expenses  2,869,058   3,137,657 
Income from operations  1,793,458   296,952 
         
Interest expense  610,896   328,608 
Income (loss) before provision for income taxes  1,182,562   (31,656)
Provision for income taxes  199,257   1,275 
Net income (loss) $983,305  $(32,931)
        
Income (loss) per common share, basic:        
Income (loss) per common share-unrestricted  shares $0.08  $(0.00)
Income (loss) per common share-restricted shares $0.08  $(0.00)
         
Income (loss) per common share, diluted $0.08  $(0.00)
         
Shares used in computing income (loss) per common share, basic:        
Unrestricted shares  12,281,115   12,072,838 
Restricted shares  239,184   290,305 
Total shares  12,520,299   12,363,143 
         
Shares used in computing income (loss) per common share, diluted  12,608,189   12,363,143 

 

See Notes to Condensed Consolidated Financial Statements


CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT) (UNAUDITED)

  Common
Stock
Shares
  Common
Stock
Amount
  Additional
Paid-in
Capital
  Accumulated
Deficit
  Total
Shareholders’
Equity (Deficit)
 
Balance at January 1, 2022  12,335,683  $12,336  $72,833,742  $(78,181,151)  (5,335,073)
Net Loss           (32,931)  (32,931)
Stock-based compensation expense  47,527   47   25,835      25,882 
Balance at March 31, 2022  12,383,210  $12,383  $72,859,577  $(78,214,082) $(5,342,122)
                     
Balance at January 1, 2023  12,506,795  $12,507  $73,189,449  $(69,004,926)  4,197,030 
Net Income           983,305   983,305 
Stock-based compensation expense  19,247   19   338,904      338,923 
Balance at March 31, 2023  12,526,042  $12,526  $73,528,353  $(68,021,621) $5,519,258 

See Notes to Condensed Consolidated Financial Statements


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

       
  For the Three Months Ended
March 31,
 
  2023  2022 
Cash flows from operating activities:        
Net income (loss) $983,305  $(32,931)
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Depreciation and amortization  116,545   171,875 
Amortization of debt issuance cost  65,835   66,166 
Stock-based compensation  338,923   25,882 
Deferred income taxes  199,993    
Bad debt expense     3,189 
Changes in operating assets and liabilities:        
(Increase) decrease in accounts receivable  (626,143)  112,188 
Increase in insurance receivable     (624,424)
Increase in contract assets  (2,978,411)  (1,296,830)
Decrease in inventory  158,502   331,795 
Decrease in prepaid expenses and other assets  6,714   209,163 
Decrease in operating right-of-use assets  455,469   435,968 
Increase in accounts payable and accrued expenses  1,217,630   111,453 
Increase (decrease) in contract liabilities  1,492,095   (1,754,748)
Increase in settlement of litigation obligation     596,741 
Decrease in lease liabilities  (425,234)  (392,181)
Decrease in loss reserve  (112,505)  (408,922)
Net cash provided by (used in) operating activities  892,718   (2,445,616)
         
Cash flows from investing activities:        
Purchase of property and equipment  (43,525)  (25,317)
Net cash used in investing activities  (43,525)  (25,317)
         
Cash flows from financing activities:        
Payments on long-term debt  (644,160)  (905,023)
Debt issuance costs paid  (54,334)   
Net cash used in financing activities  (698,494)  (905,023)
         
Net increase (decrease) in cash  150,699   (3,375,956)
Cash at beginning of period  3,847,225   6,308,866 
Cash at end of period $3,997,924  $2,932,910 
         
Supplemental disclosures of cash flow information:        
Cash paid during the period for:        
Interest $651,984  $331,441 
Income taxes $  $1,275 

See Notes to Condensed Consolidated Financial Statements


NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1.INTERIM FINANCIAL STATEMENTS

Basis of Presentation

The Company consists of CPI Aerostructures, Inc. (“CPI Aero”), Welding Metallurgy, Inc. (“WMI”), a wholly owned subsidiary of CPI Aero, and Compac Development Corporation, a wholly owned subsidiary of WMI (collectively, the “Company”, “we”, “us”, or “our”).

The condensed consolidated interim financial statements of the Company as of March 31, 2023 and for the three months ended March 31, 2023 and 2022 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations. The consolidated balance sheet at December 31, 2022 has been derived from audited consolidated financial statements, but does not include all of the information and notes required by U.S. GAAP. The Company believes that the disclosures are adequate to make the information presented not misleading.

All adjustments that, in the opinion of the management, are necessary for a fair presentation for the periods presented have been reflected. Such adjustments are of a normal, recurring nature. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”). The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis accompanied by disaggregated information about revenues for purposes of making operating decisions and assessing financial performance. The Company has determined that it has a single operating and reportable segment.

The consolidated financial statements of the Company as of September 30, 2022 and for the nine months ended September 30, 2022 and 2021 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations. The consolidated balance sheet at December 31, 2021 has been derived from audited consolidated financial statements, but does not include all of the information and notes required by U.S. GAAP. The Company believes that the disclosures are adequate to make the information presented not misleading.

All adjustments that, in the opinion of the management, are necessary for a fair presentation for the periods presented have been reflected. Such adjustments are of a normal, recurring nature. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”). The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

The Company maintains its cash in four financial institutions. The balances are insured by the Federal Deposit Insurance Corporation. From time to time, the Company’s balances may exceed insurance limits. As of September 30, 2022,March 31, 2023, the Company had $4,576,6453,830,183 of uninsured balances. The Company limits its credit risk by selecting financial institutions considered to be highly creditworthy.

Recently Issued Accounting Standards - Adopted

In the first quarter of 2023, the Company adopted ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13), using a modified retrospective method, which did not result in a significant impact on the Company’s financial statements.

 

Certain balances have been reclassified to conform to presentation requirements, including consistent presentation of the components of inventory (Note 4).

7

 

The Company currently has a shareholders’ deficit and has experienced losses from operations and negative cash flows from operations in prior periods that collectively represent significant risk to the Company to continue to operate as a going concern. To address this risk, the Company has (i) negotiated and executed a further amendment to its Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”), effective November 10, 2022 which extended the maturity date of the credit facility to November 30, 2023, (ii) obtained and is seeking additional progress payment and advance payment customer contract funding provisions, (iii) maintained procedures to reduce investments in inventory and contract assets and (iv) remained focused on its military segment and maintained a strong (approximately $118 million) backlog of funded orders, 98% of which are for military programs. Based upon management’s assessment of the identified significant risks and the execution of the plans described above, management believes that substantial risk does not exist as to whether the Company’s liquidity and debt resources will be sufficient to meet its obligations as a going concern through a year and a day from the date of this filing.  


Our business and operations and the industries in which we operate have been impacted by public and private sector policies and initiatives in the U.S. to address the transmission of COVID-19, such as the imposition of travel restrictions and the adoption of remote work. The COVID-19 pandemic has contributed to a general slowdown in the global economy, has adversely impacted the businesses of certain of our customers and suppliers, and could adversely impact our results of operations and financial condition. In response to the COVID-19 impact on our business, we have been taking actions to preserve capital and protect the long-term needs of our businesses, including negotiating progress payments with our customers and reducing discretionary spending. For more information on the current and potential impact of the COVID-19 pandemic on our business, see Risk Factors included in Part I, Item 1A of our Form 10-K.

 

2.REVENUE RECOGNITION

The Company recognizes revenue when it transfers control of a promised good or service to a customer in an amount that reflects the consideration it expects to be entitled to in exchange for the good or service. The majority of the Company’s performance obligations are satisfied over time as the Company (i) sells products with no alternative use to the Company and (ii) has an enforceable right to recover costs incurred plus a reasonable profit margin for work completed to date. This is known as the over time revenue recognition. Under the over time revenue recognition model, revenue and gross profit are recognized over the contract period as work is performed based on actual costs incurred and an estimateas a percentage of costs to complete and resulting total estimated costs at completion.completion of the contract.

The Company also has contracts that are considered point in time. Under the point in time revenue recognition model, revenue is recognized when control of the components has transferred to the customer; in most cases this will be based on shipping terms.

Contracts with Customers and Performance Obligations

The majority of the Company’s revenues are from long-term contracts with the U.S. government as well military and commercial contractors. The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. For the Company, the contract under Accounting Standards Codification Topic 606 (“ASC 606”) is typically established upon execution of a purchase order either in accordance with a long-term customer contract or on a standalone basis.

To determine the proper revenue recognition for our contracts, we must evaluate whether two or more contracts should be combined and accounted for as a single contract, and whether the combined or single contract should be accounted for as one performance obligation or more than one performance obligation. This evaluation requires significant judgment, and the decision to combine a group of contracts or to separate a contract into multiple performance obligations could change the amount of revenue and profit recorded in a period. A performance obligation is a promise within a contract to transfer a distinct good or service to the customer in exchange for payment and is the unit of account for recognizing revenue. The Company’s performance obligations in its contracts with customers are typically the sale of each individual product contemplated in the contract or a single performance obligation representing a series of products when the contract contains multiple products that are substantially the same. The Company has elected to account for shipping performed after control over a product has transferred to a customer as fulfillment activities. When revenue is recognized in advance of incurring shipping costs, the costs related to the shipping are accrued. Shipping costs are included in costs of sales. The Company provides warranties on many of its products; however, since customers cannot purchase such warranties separately and they do not provide services beyond standard assurances, warranties are not separate performance obligations.

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when or as the performance obligation is satisfied. For contracts with more than one performance obligation, the Company allocates the transaction price to each performance obligation based on its estimated standalone selling price. When standalone selling prices are not available, the transaction price is allocated using an expected cost plus margin approach as pricing for such contracts is typically negotiated on the basis of cost.

The contracts with the U.S. government and military contractors typically are subject to the Federal Acquisition Regulation, which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts. The pricing for commercial contracts is based on the specific negotiations with each customer and any taxes imposed by governmental authorities are excluded from revenue. The transaction price is primarily comprised of fixed consideration as the customer typically pays a fixed fee for each product sold. The Company does not adjust the amount of revenue to be recognized under a customer contract for the effects of the time value of money when the timing difference between receipt of payment and transferring the good or service is less than one year.

The majority of the Company’s performance obligations are satisfied over time as the Company (i) sells products with no alternative use to the Company and (ii) has an enforceable right to recover costs incurred plus a reasonable profit margin for work completed to date. The Company uses the cost-to-cost input method to measure progress for its performance obligations because it best depicts the transfer of control to the customer which occurs as the Company incurs costs on its contracts.

8

 

The Company generally utilizes the portfolio approach to estimate the amount of revenue to recognize for its contracts and groups contracts together that have similar characteristics. Contract gross profit margins are calculated using the estimated costs for either the individual contract or the portfolio as applicable. Significant judgment is used to determine which contracts are grouped together to form a portfolio. The portfolio approach is utilized only when the result of the accounting is not expected to be materially different than if applied to individual contracts.

The Company’s contracts are often modified to account for changes in contract specifications and requirements. The Company considers contract modifications to exist when the modification either creates new or changes the existing enforceable rights and obligations. The effect of a contract modification on the transaction price, and the measure of progress for the performance obligation to which it relates, are recognized prospectively when the remaining goods or services are distinct and on a cumulative catch-up basis when the remaining goods or services are not distinct.

The Company also has contracts that are considered point in time. Under the point in time revenue recognition model, revenue is recognized when control of the components has transferred to the customer; in most cases this will be based on shipping terms.customer.


Contract Estimates

Certain contracts contain forms of variable consideration, such as price discounts and performance penalties. The Company generally estimates variable consideration using the most likely amount based on an assessment of all available information (i.e., historical experience, current and forecasted performance) and only to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty is resolved.

In applying the cost-to-cost input method, the Company compares the actual costs incurred relative to the total estimated costs expected at completion to determine its progress towards satisfying its performance obligation and to calculate the corresponding amount of revenue to recognize. For any costs incurred that do not depict the Company’s performance in transferring control of goods or services to the customer, the Company excludes such costs from its input method measure of progress as the amounts are not reflected in the price of the contract. Costs that are inputs to the satisfaction of a performance obligation include labor, materials and subcontractors’ costs, other direct costs and an allocation of indirect costs.

Changes to the original estimates may be required during the life of the contract. Estimates are reviewed quarterly and the effect of any change in the total estimated gross margin percentagecosts expected at completion for a contract is reflected in revenue in the period the change becomes known. ASC 606 involves considerable use of estimates and judgment in determining revenues, costs and profits and in assigning the amounts to accounting periods. For instance, management must make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation, execution by our subcontractors, the availability and timing of funding from the customer, and overhead cost rates, among other variables. The Company continually evaluates all of the factors related to the assumptions, risks and uncertainties inherent with the application of the cost-to-cost input method; however, it cannot be assured that estimates will be accurate. If estimates are not accurate, or a contract is terminated which will affect estimates at completion, the Company is required to adjust revenue in the period the change is determined.

When changes are required for the estimated total revenue on a contract, these changes are recognized on a cumulative catch-up basis in the current period. A significant change in one or more estimates could affect the profitability of one or more of our performance obligations. If estimates of total costs to be incurred exceed estimates of total consideration the Company expects to receive, a provision for the remaining loss on the contract is recorded in the period in which the loss becomes evident.

Capitalized Contract Acquisition Costs and Fulfillment Costs

Contract acquisition costs are those incremental costs that the Company incurs to obtain a contract with a customer that it would not have incurred if the contract had not been obtained. The Company does not typically incur contract acquisition costs or contract fulfillment costs that are subject to capitalization in accordance with the guidance in Accounting Standards Codification Subtopic 340-40, “Other Assets and Deferred Costs—Contracts with Customers.”

Disaggregation of Revenue

The following tables present the Company’s revenue disaggregated by contract type and revenue recognition method:

  

Three months ended

March 31,

 
  2023  2022 
Aerostructure $10,073,525  $9,186,793 
Aerosystems  9,552,251   6,686,828 
Kitting and Supply Chain Management  2,390,892   4,261,476 
Total $22,016,668  $20,135,097 

 

  Three months ended
September 30,
  Nine months ended
September 30,
 
  2022  2021  2022  2021 
Aerostructures $9,365,065  $8,709,511  $28,371,760  $25,591,865 
Aerosystems  8,249,935   7,391,645   20,920,808   23,563,365 
Kitting and Supply Chain Management  2,581,913   7,797,592   9,964,848   27,863,454 
  $20,196,913  $23,898,748  $59,257,416  $77,018,684 
  

Three months ended

March 31,

 
  2023  2022 
Revenue recognized using over time revenue recognition model $20,630,230  $18,495,197 
Revenue recognized using point in time revenue recognition model  1,386,438   1,639,900 
Total $22,016,668  $20,135,097 

 

  Three months ended
September 30,
  Nine months ended
September 30,
 
  2022  2021  2022  2021 
Revenue recognized using over time revenue recognition model $18,462,027  $21,672,578  $53,522,920  $69,604,228 
Revenue recognized using point in time revenue recognition model  1,734,886   2,226,170   5,734,496   7,414,456 
  $20,196,913  $23,898,748  $59,257,416  $77,018,684 

9

 

Transaction Price Allocated to Remaining Performance Obligations

Our backlog represents the estimated transaction prices on performance obligations to our customers for which work remains to be performed. Backlog is converted into revenue in future periods as work is performed. As of September 30, 2022,March 31, 2023, the aggregate amount of transaction price allocated to the remaining performance obligations was approximately $118113.3 million. This represents the amount of revenue the Company expects to recognize in the future on contracts with unsatisfied or partially satisfied performance obligations as of September 30, 2022.March 31, 2023. The Company estimates that it will recognizemajority of the Company’s performance obligations have an average duration up to approximately 21four years% of this amount in fiscal year 2022 and the remainder by 2030. .


3.CONTRACT ASSETS AND CONTRACT LIABILITIES

Contract assets represent revenue recognized on contracts in excess of amounts invoiced to the customers and the where the Company’s right to consideration is conditional on something other than the passage of time. Amounts may not exceed their net realizable value. Under the typical payment terms of our government as well as military contractor contracts, the customer retains a portion of the contract price until completion of the contract, as a measure of protection for the customer. Our government and military contractor contracts therefore typically result in revenue recognized in excess of billings, which we present as contract assets. Contract assets are classified as current.current assets. The Company’s contract liabilities represent customer payments received or due from the customer in excess of revenue recognized. Contract liabilities are classified as current.current liabilities.

Schedule of contract assets and liabilities

 September 30, December 31,  March 31, December 31, 
 2022  2021  2023 2022 
Contract assets $24,157,141  $24,459,339  $30,362,951  $27,384,540 
Contract liabilities  5,041,818   5,122,766   7,493,821   6,001,726 
Net Contract assets $19,115,323  $19,336,573  $22,869,130  $21,382,814 

Revenue recognized for the periodsthree months ended September 30,March 31, 2023 and 2022 and 2021 that was included in the contract liabilities balance as of January 1, 20222023 and 2021,2022, respectively, was approximately $3.61.5 million and $1.62.5 million, respectively.

 

4.INVENTORY

The components of inventory consisted of the following:

  

March 31,

2023

  

December 31,

2022

 
Raw materials $1,921,845  $1,892,157 
Work in progress  609,372   685,438 
Finished goods  3,027,697   3,038,859 
Gross inventory  5,558,914   5,616,454 
Inventory reserves  (3,224,347)  (3,123,386)
Inventory, net $2,334,567  $2,493,069 

 

  

September 30,  

2022 

  

December 31,  

2021 

 
Raw materials $1,843,761  $2,033,216 
Work in progress  1,078,677   1,413,672 
Finished goods  3,202,658   3,568,192 
Gross inventory  6,125,096   7,015,080 
Inventory reserves  (3,016,855)  (2,986,155)
Inventory, net $3,108,241  $4,028,925 


5.STOCK-BASED COMPENSATION

The Company accounts for stock-based compensation based on the fair value of the stock or stock-based instrument on the date of grant. The Company recognized a net total of $84,978 and $154,649 of stock-basedStock-based compensation expense for restricted stock in the three months ended September 30, 2022 and 2021, respectively, and a net totalconsolidated statements of $operations is summarized as follows:

248,359 and $723,474 of stock- based compensation expense for the nine months ended September 30, 2022 and 2021, respectively.

  2023  2022 
Cost of sales $15,077  $13,534 
Selling, general and administrative  323,846   12,348 
Total stock-based compensation expense $338,923  $25,882 

 

During the three and nine months ended September 30, 2022, theThe Company granted 0 and 190,114grants restricted stock units (“RSUs”), respectively, to its board of directors as partial compensation for the 2022 year, and during the three and nine months ended September 30, 2021, the Company granted 0 and 135,512 RSUs, respectively, to its board of directors as partial compensation for the 2021 year.compensation. These RSUs vest quarterly on a straight-line basis over a one-year period. For the three and nine months ended September 30, 2022, $61,272 and $393,891, respectively, of non-cash compensation expense related to the RSU grants to the board of directors are included selling, general and administrative expenses, and for the three and nine months ended September 30, 2021, $79,638 and $511,983, respectively, of non-cash compensation expense related to the RSU grants to the board of directors are included in selling, general and administrative expenses.

During the three and nine months ended September 30, 2022, theThe Company granted 0 and 18,588grants shares of common stock (“Restricted Stock”Stock Awards”) to select employees. In the event that thisthe employee’s employment is voluntarily terminated prior to certain vesting dates, portions of the shares may be forfeited. For the three and nine months ended September 30, 2022, $In addition, if certain Company performance criteria are not achieved, portions of these shares may be forfeited. 17,23585,748 and $(172,009), respectively, of compensation expense are included in selling, general and administrative expenses, which includes forfeituresshares were forfeited during the three months ended March 31, 2022, of 171,495 shares totaling ($263,148) of credit. Forresulting in a reduction to stock-based compensation expense for the three and nine months ended September 30,March 31, 2022 $6,471 and $26,477, respectively, of compensation expense are included in cost of sales for shares of common stock granted to employees between 2018 and 2022. For the three and nine months ended September 30, 2021, $61,434 and $173,536, respectively, of compensation expense are included in selling, general and administrative expensesexpense of $263,148.

The following table summarizes activity related to outstanding RSUs and $13,577 and $37,955, respectively, of compensation expense are included in cost of salesRestricted Stock Awards for shares of common stock granted to employees between 2016 and 2020. During the three and nine months ended September 30, 2021, 41,199March 31, 2023: shares were forfeited.

              
   Restricted Stock Awards  

Weighted Average

Grant Date

Fair Value of Restricted Stock Awards

  RSUs  

Weighted Average

Grant Date

Fair Value of RSUs

 
Non-vested – January 1, 2023   239,184  $2.32     $ 
Granted     $   162,188  $3.42 
Vested     $   (40,549) $3.42 
Forfeited     $   (33,749) $3.42 
Non-vested – March 31, 2023   239,184  $2.32   87,890  $3.42 

 

As of March 31, 2023, unamortized stock-based compensation costs related to restricted share arrangements was $313,582.

6.FAIR VALUE

Fair Value

At September 30, 2022March 31, 2023 and December 31, 2021,2022, the fair values of cash, accounts receivable and accounts payable approximated their carrying values because of the short-term nature of these instruments.

       
  March 31, 2023 
  

Carrying

Amount

  Fair Value 
Debt      
Short-term borrowings and long-term debt $22,146,587  $22,146,587 

 

  September 30, 2022 
  Carrying
Amount
  Fair Value 
Debt      
Short-term borrowings and long-term debt $23,692,303  $23,692,203 
         
  December 31, 2021 
  Carrying
Amount
  Fair Value 
Debt      
Short-term borrowings and long-term debt $26,155,928  $26,155,928 
         
  December 31, 2022 
  

Carrying

Amount

  Fair Value 
Debt      
Short-term borrowings and long-term debt $22,790,747  $22,790,747 

 

We estimated the fair value of debt using market quotes and calculations based on market rates.

11

 

 

7.INCOME (LOSS) PER COMMON SHARE

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share” and uses the two-class method in the calculation of earnings per share. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. During the three months ended March 31, 2023 and 2022, respectively, and as of March 31, 2023 and 2022, respectively, the Company had restricted shares of common stock that were considered participating securities and unrestricted shares of common stock outstanding. Earnings and losses are shared pro rata.

 

Basic and diluted income (loss) per common share for the three and six months ended September 30, 2022 and 2021 is computed using the weighted average number of common shares outstandingoutstanding. Diluted income (loss) per common share is adjusted for the incremental shares attributed to outstanding options to purchase common stock, as well as unvested RSUs. Incremental shares of 47,53187,890 were used in the calculation of diluted income per common share infor the three and nine months ended September 30, 2022.March 31, 2023. Incremental shares of 33,876142,587 were not used in the calculation of diluted income per common share infor the three and nine months ended September 30, 2021. March 31, 2022, as the Company was in a loss position for the three months ended March 31, 2022 and these shares would be considered anti-dilutive.


For the three months ended March 31, 2023 and 2022, respectively, our income (loss) per common share was calculated as follows:

  Three months
ended March 31,
2023
  Three months
ended March 31,
2022
 
Net income (loss) $983,305  $(32,931)
         
Income (loss) per common share, basic:        
Income (loss) per common share-unrestricted shares $0.08  $(0.00)
Income (loss) per common share-restricted shares $0.08  $(0.00)
         
Income (loss) per common share, diluted $0.08  $(0.00)
         
Shares used in computing income (loss) per common share, basic:        
Unrestricted shares  12,281,115   12,072,838 
Restricted shares  239,184   290,305 
Total shares  12,520,299   12,363,143 
         
Shares used in computing income (loss) per common share, diluted  12,608,189   12,363,143 

8.DEBT

Credit Facility

On March 24, 2016, the Company entered into the Amended and Restated Credit Agreement.Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The BankUnited Facility originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate based upon a pricing grid, as defined in the Credit Agreement.

On May 11, 2021,March 23, 2023, the Company entered into the Seventha Twelfth Amendment to the Credit Agreement (the “Seventh“Twelfth Amendment”). Under the SeventhTwelfth Amendment, the parties amended the Credit Agreement by : (a) extending the maturity date of the Revolving LoanCompany’s existing revolving line of credit and the Term Loanits existing term loan to November 30, 2024 (under the terms of the Credit Agreement, the outstanding principal balance of the term loan will be repaid by June 30, 2023); (b) providing for reduction of the aggregate maximum principal amount of all revolving line of credit loans to $20,520,000 from October 1, 2023 through December 31, 2023, $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 31, 2022,1, 2024 through September 30, 2024, and (b) amending the leverage ratio covenant. Additionally, under the Seventh Amendment, BankUnited waived late delivery of certain financial information.

On$17,640,000 from October 28, 2021,1, 2024 and thereafter, and for payments to be made by the Company entered intoto comply therewith (if any such payments are necessary), on the first day of each such period; and (c) payment of a Waiver and$250,000 capitalized fee incurred in connection with the Eighth Amendment to the Credit Agreement, (the “Eighth Amendment”). Under the Eighth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Revolving Loan and the Term Loan to December 31, 2022, (b) reducing the availability under the Revolving Loan from $24 million to $21 million while eliminating the requirement to maintain a minimum $3.0 million in a combination of Revolving Loan availability and unrestricted cash, (c) providing for the repayment of an additional $750,000 of the principal balance of the Term Loan in three installments of $250,000 on November 30, 2021, December 31, 2021 and March 31, 2022 in addition to $200,000 regular monthly principal payments through December 31, 2022, (d) amending the minimum debt service coverage ratio covenant, (e) amending the maximum leverage ratio covenant. Additionally, under the Eighth Amendment, BankUnited waived certain covenant non-compliance and waived temporarily, late delivery of certain financial information. In connection with the Eighth Amendment, a $250,000 amendment fee (the “Amendment Fee”) was earned by the lenders on December 31, 2021 which the Company elected to pay in kind and accrue and capitalize rather than pay in cash. As at December 31, 2021, the Amendment Fee payable was posted by BankUnited to the Revolving Loan and on February 11, 2022, in agreement with the Company, the Amendment Fee was reclassified by BankUnited to the Term Loan. The Company has recorded this payable to its financial statements accordingly.

On April 12, 2022 the Company entered into a Consent, Wavier and Ninth Amendmenton October 28, 2021 (the “Eighth Amendment”) in two installments, the first installment to be paid on June 1, 2023 in the Credit Agreement (the “Ninth Amendment”). Under the Ninth Amendment, the parties amended the Credit Agreement by (a) extending the maturity dateamount of the Revolving Loan$116,667 and the Term Loansecond installment to September 30,be paid July 1, 2023, (b) providing for in the repayment of an additional $750,000 of the principal balance of the Term Loan in three installmentsamount of $250,000133,333 on September 30, 2022, December 31, 2022 and March 31, 2023 in addition to $200,000 regular monthly principal payments through December 31, 2022 and (c) increasing the, together with all unpaid interest on the Revolving Loan, Term Loan, and the Amendment Fee as follows: through June 30, 2022, Prime Rate (as defined in the Credit Agreement) plus 2.5%; from July 1, 2022 through August 31, 2022, Prime Rate plus 5%; from September 1, 2022 through October 31, 2022, Prime Rate plus 6%; from November 1, 2022 through December 31, 2022, Prime Rate plus 7%; and from January 1, 2023 through September 30, 2023, Prime Rate plus 8%. Additionally, under the Ninth Amendment, the Credit Agreement financial covenants were amended. BankUnited also waived or consented to certain covenant non-compliance, waived temporarily or consented to, late delivery of certain financial information and waived permanently late delivery of certain pro-forma budget information.

On August 19, 2022, the Company entered into a Consent, Waiver and Tenth Amendment to the Credit Agreement (the “Tenth Amendment”). Under the Tenth Amendment, the parties amended the Credit Agreement by (a) increasing the maximum leverage ratio applicable for the fiscal quarter ending September 30, 2022 to 5.0, (b) waiving and/or consenting to the exclusion from the Company’s covenant compliance requirements for the fiscal quarters ended December 31, 2021, March 31, 2022, June 30, 2022 and September 30, 2022 up to (i) $566,024.81 of losses incurred and reserves taken under the Borrower’s welded product contracts, and (ii) $367,044.51 of reserves taken with respect to the Borrower’s welded product inventory, and (c) waiving and/or consenting to the exclusion from the Company’s covenant compliance requirements for the fiscal quarters ended March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022 up to $795,997.06 of accrued severance and COBRA costs and employer taxes incurred by the Company during the fiscal quarter ending March 31, 2022. Additionally, under the Tenth Amendment, BankUnited waived or consented to late delivery of certain financial information required by the Credit Agreement.

On November 10, 2022, the Company entered into an Eleventh Amendment to the Credit Agreement (the “Eleventh Amendment”). Under the Eleventh Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Revolving Loan and the Term Loan to November 30, 2023 or with respect to the Term Loan, if earlier, until the outstanding principal balance is paid in full (the “Term Loan Maturity Date”), (b) providing for regular monthly principal payments of $200,000 on the Term Loan from January 1, 2023 through the Term Loan Maturity Date (in addition to the Company’s existing obligation to make two principal payments onat the term loan of $250,000 on each of December 31, 2022 and March 31, 2023) and (c) decreasing the interest rate on the Revolving Loan, the Term Loan and the Amendment Fee to the Prime Rate plus 3.5capitalized fee through each such date.% effective as of November 1, 2022.

The Credit Agreement, as amended, requires us to maintain the following financial covenants (subject to the exclusions provided for in the previous paragraph): (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for the trailing four quarter period ended March 31, 2022, 0.95 to 1.0 for the trailing four quarter period ended June 30, 2022, and 1.5 to 1.0 for the trailing four quarter period ended September 30, 2022 and for the trailing four quarter periods ended thereafter; (b) maximum leverage ratio of no less than 7.30 to 1.0 for the trailing four quarter period ended March 31, 2022, 6.30 to 1.0 for the trailing four quarter period ended June 30, 2022, and 5.0 to 1.0 for the trailing four quarter period ended September 30, 2022 and 4.0 to 1.0 for the trailing four quarter periods thereafter; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00 commencing June 30, 2022; and (d) a minimum adjusted EBITDA at the end of each quarter of no less than $1.0 million (waived for the quarter ended March 31, 2022). The additional principal payments, increase in interest and the Amendment Fee provided for in the Eight Amendment and Ninth Amendment to the Credit Agreement, which the Company entered into on April 12, 2022 (the “Ninth Amendment”) are excluded for purposes of calculating compliance with each of the financial covenants.

The BankUnited Facility is secured by all of the Company’s assets and both the Revolving Loan and Term Loan borebear interest at the rate of 12.25% (the Prime Rate of 6.25% + 6.003.50%). The Prime Rate was 8.00% as of September 30, 2022.March 31, 2023 and as such, the Company’s interest rate on the Revolving Loan and Term Loan was 11.50% as of March 31, 2023.

As of September 30,March 31, 2023 and December 31, 2022, the Company had $21,000,000 million outstanding under the Revolving Loan. $1,920,000 of the Revolving Loan as compared tois payable by March 31, 2024 and the remaining balance of $21,250,00019,080,000 as of December 31, 2021.the revolving line of credit matures and is payable by November 30, 2024.

The Term Loan as amended by the Eleventh Amendment, had an aggregate principal amount of $2,433,333983,333, payable in monthly installments, as defined in the agreement, as of September 30, 2022March 31, 2023 as compared to an aggregate principal amount outstanding as of December 31, 20212022 of $4,483,3331,583,333.

There is currently no availability for borrowings under the Revolving Loan and the Company finances its operations from internally generated cash flow.

PPP Loan

On April 10, 2020, we entered into the Paycheck Protection Program loan (“PPP Loan”), with BNB Bank (now part of Dime Community Bank (“Dime”)) as the lender, in an aggregate principal amount of $4,795,000, pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”). The PPP Loan was evidenced by a promissory note (the “Note”). Subject to the terms of the Note, the PPP Loan bore interest at a fixed rate of one percent (1%) per annum, with the first six months of interest deferred, had an initial term of two years, and was unsecured and guaranteed by the Small Business Administration (“SBA”). The Note provided for customary events of default including, among other things, cross-defaults on any other loan with the lender. The PPP Loan could have been accelerated upon the occurrence of an event of default. 


On November 2, 2020, the Company applied to the lender for full forgiveness of the PPP Loan as calculated in accordance with the terms of the CARES Act, as modified by the Paycheck Protection Flexibility Act. All amounts have been classified as current or long term in accordance with the Note terms.

On July 13, 2021, the Company received notification through Dime that the PPP Loan and accrued interest thereon had been fully forgiven by the SBA and that the forgiveness payment date was July 1, 2021. The forgiveness of the PPP Loan was recognized as other income during the Company’s third fiscal quarter ending September 30, 2021. The SBA reserves the right to audit any PPP Loan, for eligibility and other criteria, regardless of size. These audits may occur after forgiveness has been granted. In accordance with the CARES Act, all borrowers are required to maintain their PPP loan documentation for six years after the PPP Loan was forgiven and to provide that documentation to the SBA upon request.

The maturities of long-term debt (excluding unamortized debt issuance costs) are as follows:

Twelve months ending September 30,    
2023  $2,591,927 
For the Year Ending December 31,    
Remainder of 2023  $1,065,758 
2024   66,311    51,801 
2025   31,330    29,028 
2026   2,735 
Total  $2,692,303   $1,146,587 

 

Included in the long-term debt are financing leases and other notes payable of $258,970163,254 and $422,595207,414 at September 30, 2022March 31, 2023 and December 31, 2021,2022, respectively, including a current portion of $158,594114,508 and $215,181136,433, respectively.

12

 

The Company has cumulatively paid approximately $908,000962,000 of total debt issuance costs in connection with the BankUnited Facility, of which approximately $174,219119,000 is included in other assets at September 30, 2022.March 31, 2023.

13

 

 

9.MAJOR CUSTOMERS

During the ninethree months ended September 30,March 31, 2023, our two largest customers accounted for 36% and 28% of revenue. During the three months ended March 31, 2022, the Company’sour three largest customers accounted for 3839%, 1417% and 12% of revenue. During the nine months ended September 30, 2021, the Company’s four largest customers accounted for

34

At March 31, 2023, 25%, 21%,11% and 10% of revenue.

At September 30, 2022, 3417%, 2217%, 10% and 1015% of our contract assets were from four of our largest customers. At December 31, 2021,2022, 3427%, 20%, 16%, and 1216% of our contract assets were from three ofrelated to our four largest customers.

At September 30, 2022,March 31, 2023, 27%, 1729%, 16%, 14%, 12% and 1211% of our accounts receivable were from our five largest customers. At December 31, 2021,2022, 3038%, 2321%, 17%, and 1813% of accounts receivable were due from our threefour largest customers.

 

10.LEASES

The Company leases a building and equipment. Under ASC 842, at contract inception we determine whether the contract is or contains a lease and whether the lease should be classified as an operating or a financing lease. Operating leases are included in ROU (right-of-use) assets and operating lease liabilities in our consolidated balance sheets.

The Company leases manufacturing and office space under an agreement classified as an operating lease.

On November 10, 2021, the Company executed the second amendment to the lease agreement for its manufacturing and office space, which extends the lease agreement’s expiration date to April 30, 2026. The lease agreement as amended, expires on April 30, 2026 and does not include any renewal options. The agreement provides for an initial monthly base amount plus annual escalations through the term of the lease.

In addition to the monthly base amounts in the lease agreement, the Company is required to pay real estate taxes and operating expenses during the lease terms.

The Company also leases office equipment in agreements classified as operating leases.

For the three and nine months ended September 30,March 31, 2023 and 2022, the Company’s operating lease expense was $529,004546,082 and $1,579,879534,991, respectively.

Future minimum lease payments under non-cancellable operating leases as of September 30, 2022March 31, 2023 were as follows:

For the Year Ending December 31,    
Remainder of 2023  $1,624,406 
2024   2,222,280 
2025   2,276,850 
2026   843,772 
2027   109,394 
Thereafter   7,331 
Total undiscounted operating lease payments   7,084,033 
Less imputed interest   (614,221)
Present value of operating lease payments  $6,469,812 

 

Twelve months ending September 30,    
2023  $2,055,806 
2024   2,151,496 
2025   2,202,321 
2026   1,330,474 
2027   60,416 
Total undiscounted operating lease payments   7,800,513 
Less imputed interest (between 4.0% - 10.5%)   (725,887)
Present value of operating lease payments  $7,074,626 

14

 

The following table sets forth the ROU assets and operating lease liabilities as of September 30, 2022:of:

 

March 31,
2023

  December 31,
2022
 
Assets        
ROU assets-net $6,736,441 
ROU assets, net $6,071,158  $6,526,627 
            
Liabilities            
Current operating lease liabilities $1,728,707  $1,872,484  $1,817,811 
Long-term operating lease liabilities  5,345,919   4,597,328   5,077,235 
Total ROU liabilities $7,074,626 
Total lease liabilities $6,469,812  $6,895,046 

 

The amortization expense of these assets under operating leases was $455,392 and $435,968 for the three months ended March 31, 2023 and 2022, respectively.

The Company’s weighted average remaining lease term for its operating leases is 3.63.2 years. years as of March 31, 2023. The Company’s weighted average discount rate for its operating leases is 5.4% as of March 31, 2023.


11.INCOME TAXES

Income taxes are accounted for under the asset and liability method whereby deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the consolidated financial statements carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company’s policy is to record estimated interest and penalties related to uncertain tax positions in income tax expense.

The provision for income tax for the three months ended September 30,March 31, 2023 and 2022 and 2021 was $3,750199,257 and $3,3741,275, respectively. The increase in the provision for income tax is the result of the Company’s valuation allowance on its deferred tax asset being partially released at December 31, 2022, resulting in the change in the deferred asset for the ninethree months ended September 30,ending March 31, 2023 being recorded through the Company’s statement of operations for the three months ending March 31, 2023. For the three months ending March 31, 2022 and 2021the company’s deferred tax assets were fully offset by the valuation allowance, therefore there was $11,250only minimum state tax income expense recorded to the Company’s statement of operations during the three months ending March 31, 2022. and $7,702, respectively.

 

The effective income tax rate for the three months ended March 31, 2023 is 16.8%. The difference between the effective income tax rate for the three months ended March 31, 2023 and the statutory income tax rate of 21% for the three months ended March 31, 2023 is due to the estimated R&D credit, state income taxes and permanent tax differences.

The difference between the Company’s statutory tax rate and its effective rate is due to the valuation allowance taken on the Company’s net operating loss carryforwards.R&D credit and permanent tax differences.

12.COMMITMENTS AND CONTINGENCIES

Class Action Lawsuit

As previously disclosed, aA consolidated class action lawsuit (captioned Rodriguez v. CPI Aerostructures, Inc., et al., No. 20-cv-00982) has been20-cv-01026) was filed in the U.S. District Court for the Eastern District of New York against the Company, Douglas McCrosson;McCrosson, the Company’s former Chief Executive Officer;Officer, Vincent Palazzolo, the Company’s former Chief Financial Officer;Officer, and the two underwriters of the Company’s October 16, 2018 offering of common stock, Canaccord Genuity LLC and B. Riley FBR. The Amended Complaint in the action assertsasserted claims on behalf of two plaintiff classes: (i) purchasers of the Company’s common stock issued pursuant to and/or traceable to the Company’s offering conducted on or about October 16, 2018; and (ii) purchasers of the Company’s common stock between March 22, 2018 and February 14, 2020. The Amended Complaint allegesalleged that the defendants violated Sections 11, 12(a)(2), and 15 of the Securities Act of 1933, as amended (the “Securities Act”), by negligently permitting false and misleading statements to be included in the registration statement and prospectus supplements issued in connection with its October 16, 2018 securities offering. The Amended Complaint also allegesalleged that the defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10b-5 promulgated by the SEC, by making false and misleading statements in the Company’s periodic reports filed between March 22, 2018 and February 14, 2020. Plaintiff seekssought unspecified compensatory damages, including interest; rescission or a rescissory measure of damages; unspecified equitable or injunctive relief; and costs and expenses, including attorney’s fees and expert fees. On February 19, 2021, the Company moved to dismiss the Amended Complaint. Plaintiff submitted a brief in opposition to the motion to dismiss on April 23, 2021.

On May 20, 2021, the parties reached a settlement in the amount of $3,600,000 (the “Settlement Amount”), subject to court approval. On July 9, 2021, Plaintiff filed an unopposed motion for preliminary approval of the settlement. On November 10, 2021, a magistrate judge recommended that the Courtcourt grant the motion for preliminary approval in its entirety. The Courtcourt adopted the recommendation on May 27, 2022, and entered an order granting preliminary approval of the settlement on June 7, 2022. On August 5, 2022, the Plaintiff filed an unopposed motion for final approval. The magistrate judge held a hearing on the final approval motion on September 9, 2022, and is now deciding whether to recommend2022. On February 16, 2023, the magistrate judge recommended that the Court grant the final approval ofmotion in its entirety. The Court adopted that recommendation in its entirety on March 10, 2023, and terminated the settlement. As of September 30, 2022, we have previously paid and accrued to our financial statements covered expenses totaling $750,000, and have therefore met our insurance carrier’s directors’ and officers’ retention requirement, which capscase on March 13, 2023. On May 5, 2023, the Company’s expenses pertainingSettlement Amount was transferred to the class action suit.

At September 30, 2022, in order to reflect the amounts owed from our directors’ and officers’ insurance carrier and to the Plaintiffs, we have recorded to our balance sheet a litigation settlement obligation of $3,600,000 and an insurance recovery receivable of $3,600,000 to reflect the liability owed by the Company to the Plaintiffs as well as the amount receivable owingPlaintiff from the Company’s insurance carrier to the Company with respect to the settlement obligation.escrow account established for this purpose.

Shareholder Derivative Action

Four shareholder derivative actions, each based on substantially the same facts as those alleged in the class action discussed above, have been filed against current members of our board of directors and certain of our current and former directors and officers.

The first action (captioned Moulton v. McCrosson, et.al., No. 20-cv-02092) was filed in the United StatesU.S. District Court for the Eastern District of New York. It purports to assert derivative claims against the individual defendants for violations of Section 10(b) and 21D of the Exchange Act, breach of fiduciary duty, and unjust enrichment and seeks to recover on behalf of the Company for any liability the Company might incur as a result of the individual defendants’ alleged misconduct. The complaint also seeks declaratory, equitable, injunctive, and monetary relief, as well as attorneys’ fees and other costs. On October 26, 2020, the plaintiff filed an amended complaint. On January 27, 2021, the Courtcourt stayed the action pursuant to a joint stipulation filed by the parties.

15

 

The second action (captioned Woodyard v. McCrosson, et al., Index No. 613169/2020) was filed on September 17, 2020, in the Supreme Court of the State of New York (Suffolk County). It purports to assert derivative claims against the individual defendants for breach of fiduciary duty and unjust enrichment, and seeks to recover on behalf of the Company for any liability the Company might incur as a result of the individual defendants’ alleged misconduct, along with declaratory, equitable, injunctive and monetary relief, as well as attorneys’ fees and other costs. On December 22, 2020, the parties filed a joint stipulation staying the action pending further developments in the class action.

The third action (captioned Berger v. McCrosson, et al., No. 1:20-cv-05454) was filed on November 10, 2020, in the United StatesU.S. District Court for the Eastern District of New York. The complaint, which is based in part on the shareholder’s inspection of certain corporate books and records, purports to assert derivative claims against the individual defendants for breach of fiduciary duty and unjust enrichment, and seeks to implement reforms to the Company’s corporate governance and internal procedures and to recover on behalf of the Company an unspecified amount of monetary damages. The complaint also seeks equitable, injunctive, and monetary relief, as well as attorneys’ fees and other costs.

On March 19, 2021, the parties to the Moulton and Berger actions filed a joint stipulation consolidating the actions (under the caption In re CPI Aerostructures Stockholder Derivative Litigation, No. 20-cv-02092) and staying the consolidated action pending further developments in the class action.

13 

 

The fourth action (captioned Wurst v. Bazaar, et al., Index No. 605244/2021) was filed on March 24, 2021, in the Supreme Court of the State of New York (Suffolk County). The complaint purports to assert derivative claims against the individual defendants for breach of fiduciary duty, unjust enrichment, and waste of corporate assets, and seeks to recover on behalf of the Company for any liability the Company might incur as a result of the individual defendants’ alleged misconduct. The complaint also seeks declaratory, equitable, injunctive, and monetary relief, as well as attorneys’ fees and other costs. On April 12, 2021, the parties filed a joint stipulation staying the action pending further developments in the class action.

 

On June 13, 2022, the plaintiffs in the consolidated federal action informed the Courtcourt that the Company (as nominal defendant) and all individual defendants had reached an agreement in principle with all plaintiffs to settle the four shareholder derivative lawsuits described above. On June 16, 2022, the plaintiffs in the consolidated federal action filed an unopposed motion for preliminary approval of the settlement. On July 22, 2022, the Courtcourt referred the motion to the magistrate judge; the motion remains pending.judge. The magistrate judge held a conference on September 9, 2022 in the consolidated federal action. On February 14, 2023, the magistrate judge recommended that the court grant the motion in its entirety.

On March 6, 2023, the court granted preliminary approval of the proposed settlement. The proposed settlement is subject to final approval by the court. In addition to requiring final approval by the court, the proposed settlement is subject to certain conditions, including the filing with the SEC of the stipulation of settlement agreed to by the Company and plaintiff (the “Stipulation of Settlement”), and sending notice to potential class members. The terms of the proposed settlement are set forth in the Stipulation of Settlement. Should the proposed settlement receive final approval from the Court, approval and, if approved,it will result in the dismissal of the shareholder derivative lawsuits. As part of the proposed settlement, the Company has agreed to undertake (or confirm that it has undertaken already) certain corporate governance reforms andreforms. In addition, the Company and/or its insurer have agreed to pay a total of $585,000 in attorneys’ fees to plaintiffs’ counsel.

Litigation Settlement Obligation and Insurance Recovery Receivable Pertaining to the Class Action Lawsuit and Shareholder Derivative Action

The attorneys’ fees for both the Class Action Lawsuit and the Shareholder Derivative Action will be covered and paid by our directors’ and officers’ insurance carrier, after satisfaction of our $750,000 retention. As of March 31, 2023, we have previously paid and accrued to our financial statements covered expenses totaling $750,000, and have therefore met our insurance carrier’s directors’ and officers’ retention requirement, which caps the Company’s expenses pertaining to the class action suit at $750,000. As of March 31, 2023, in order to reflect the amounts owed from our directors’ and officers’ insurance carrier and to the Plaintiffs, we have recorded to our balance sheet a litigation settlement obligation of $3,600,000 and an insurance recovery receivable of $3,600,000 owing from the Company’s insurance carrier to the Company with respect to the settlement obligation; this obligation and receivable will be relieved from our balance sheet following the transfer of the Settlement Amount to the Plaintiff from the escrow account established for this purpose.

16

 

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with the Company’s consolidated financial statements and notes thereto contained in this report.

 

Forward Looking Statements

 

When used in this Form 10-Q and in future filings by us with the Securities and Exchange Commission (the “SEC”), the words or phrases “will likely result,” “management expects” or “we expect,” “will continue,” “is anticipated,” “estimated” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The risks are included in Part I, Item 1A – Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 20212022 (the “Form 10-K”). We undertakehave no obligation to publicly updaterelease the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

 

Business Operations

 

We are engaged in the contract production of structural aircraft parts for fixed wing aircraft and helicopters in both the defensecommercial and commercialdefense markets. We also have a strong and growing presence in the aerosystems segmentsector of the market, with our production of various reconnaissance pod structures and fuel panel systems. Within the global aerostructure and aerosystem supply chain, we are either a Tier 1 supplier to aircraft Original Equipment Manufacturersoriginal equipment manufacturers (“OEMs”) or a Tier 2 subcontractor to major Tier 1 manufacturers. We also are a prime contractor to the U.S.United States Department of Defense (“DOD”), primarily the U.S.United States Air Force.Force (“USAF”). In conjunction with our assembly operations, we provide engineering, program management, supply chain management and kitting, and maintenance, repair and overhaul (“MRO”) services.

 

Impact of COVID-19

 

Our business and operations and the industries in which we operate have been impacted by public and private sector policies and initiatives in the U.S. to address the transmission of COVID-19, such as the imposition of travel restrictions and the adoption of remote work. The COVID-19 pandemic has contributed to a general slowdown in the global economy, has adversely impacted the businesses of certain of our customers and suppliers, and could adversely impact our results of operations and financial condition. In response to the COVID-19 impact on our business, we have been taking actions to preserve capital and protect the long-term needs of our businesses, including negotiating progress payments with our customers and reducing discretionary spending. For more information on the current and potential impact of the COVID-19 pandemic on our business, see Risk Factors included in Part I, Item 1A of our Form 10-K.

 

Recent Developments

 

NYSE American Trading Resumption and Delinquency Notice

On May 19, 2022, the NYSE American exchange (the “Exchange”) announced the suspension of trading of our common stock due to non-compliance with the SEC annual and quarterly report timely filing criteria provided for in Section 1007 of the Exchange’s Company Guide (the “Company Guide”) and announced that it was initiating proceedings to delist our common stock. On September 29, 2022, we became current with our SEC reports upon the filing of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022. On September 30, 2022, we were informed by the Exchange that the Exchange terminated its proceeding to delist our common stock. Trading of our common stock recommenced on the Exchange on October 5, 2022, under the symbol “CVU.”

14

On SeptemberMarch 17, 2021,2023, we received notice from the Exchange indicatingNYSE American (the “Exchange”) that the Company does not meetis in compliance with all of the NYSE American LLC continued listing standards set forth in Part 10 of the NYSE American Company Guide. The Guide (“Company is not in complianceGuide”), and that, specifically, the Company has resolved the continued listing deficiency with Sectionrespect to Sections 1003(a)(i) of the Company Guide since it has stockholders’ equity of less than $2.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years and Section 1003(a)(ii) of the Company Guide since it has stockholders’ equity of less than $4.0 million and losses from continuing operations and/or net lossesreferenced in three of its four most recent fiscal years. The Company is therefore subjectthe Exchange’s letter to the procedures and requirements of Section 1009 ofCompany dated September 17, 2021, which was previously disclosed by the Company Guide and was required to, and timely did, submit a plan to the Exchange addressing how the Company intends to regain compliance with the continued listing standards by March 17, 2023 (the “Plan”). On November 19, 2021, we received notice from the Exchange that it accepted the Plan, subject to periodic review, including quarterly monitoring, for compliance with the Plan. If the Company (i) does not make progress consistent with the Plan during the plan period or (ii) is not in compliance with the continued listing standards by March 17, 2023, the Exchange staff may initiate delisting proceedings as appropriate.Company.

 

AmendmentBacklog

We produce custom assemblies pursuant to long-term contracts and Waivercustomer purchase orders. Funded backlog consists of aggregate funded values under such contracts and purchase orders, excluding the portion previously included in operating revenues pursuant to Accounting Standards Codification Topic 606 (“ASC 606”). Unfunded backlog is the estimated amount of future orders under the expected duration of the programs. Substantially all of our BankUnitedbacklog is subject to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore, our funded backlog does not include the full value of our contracts.

17

Our total backlog as of March 31, 2023 and December 31, 2022 was as follows:

Backlog
(Total)
 March 31,
2023
  December 31,
2022
 
Funded $113,295,000  $122,148,000 
Unfunded  402,520,000   392,352,000 
Total $515,815,000  $514,500,000 

Approximately 98% of the total amount of our backlog at March 31, 2023 was attributable to government and military contractor contracts. Our backlog attributable to government and military contractor contracts at March 31, 2023 and December 31, 2022 was as follows:

Backlog
(Government/Military Contractors)
 March 31,
2023
  December 31,
2022
 
Funded $110,466,000  $119,133,000 
Unfunded  394,345,000   384,652,000 
Total $504,811,000  $503,785,000 

Our backlog attributable to commercial contracts at March 31, 2023 and December 31, 2022 was as follows:

Backlog
(Commercial)
 March 31,
2023
  December 31,
2022
 
Funded $2,829,000  $3,015,000 
Unfunded  8,175,000   7,700,000 
Total $11,004,000  $10,715,000 

The total backlog at March 31, 2023 is primarily comprised of long-term programs with Raytheon (Next Generation Jammer – Mid Band Pod), USAF (T-38), Boeing (A-10 Main Landing Gear Pod), Northrop Grumman (E-2D), Raytheon (B-52 Radar Rack), Collins Aerospace (MS-110 Pod), and Sikorsky UH-60 Gunner Window, Stabilator MRO and IR Module Assembly (HIRSS). Funded backlog is primarily from purchase orders under long-term contracts with USAF (T-38), Boeing (A-10 Main Landing Gear Pod), Sikorsky IR Module Assembly (HIRSS), Lockheed Martin F-16 Rudder Island, Northrop Grumman (E-2D) and Raytheon (Next Generation Jammer – Mid Band Pod).

Critical Accounting Policies

We make a number of significant estimates, assumptions and judgments in the preparation of our financial statements. See Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Form 10-K, for a discussion of our critical accounting policies. There have been no significant changes to the application of our critical accounting policies during the quarter ended March 31, 2023.

Results of Operations

Revenue

Total Revenue for the three months ended March 31, 2023 was $22,016,668 compared to $20,135,097 for the same period last year, an increase of $1,881,571 or 9.3%. The increase was primarily related to increases in Raytheon Next Generation Jammer (“NGJ”) Pods and Lockheed Martin F-16V Rudder Island and Drag Chute Canisters (“RI/DCC”), partly offset by decreases in Northrop Grumman E-2D Advanced Hawkeye Wet Outer Wing Panels (“WOWP”) , Sikorsky UH-60 BLACKHAWK Hover Infrared Suppression System (“HIRSS”) Module Assemblies and GKN UH-60 BLACKHAWK Inlet Ducts.

Revenue from military subcontracts was $18,672,893 for the three months ended March 31, 2023 compared to $17,196,495 for the three months ended March 31, 2022, an increase of $1,476,398 or 8.6%. The increase was primarily related to increases in Raytheon NGJ Pods and Lockheed Martin F-16V RI/DCC Module Assemblies, partly offset by decreases in Northrop Grumman WOWP’s, Sikorsky UH-60 BLACKHAWK HIRRS Module Assemblies, GKN UH-60 BLACKHAWK Inlet Ducts and Sikorsky UH-60 BLACKHAWK Fuel Panels.

Revenue from government military contracts was $1,408,034 for the three months ended March 31, 2023 compared to $1,529,472 for the three months ended March 31, 2022, a decrease of $121,438 or 7.9%. The decrease was primarily related to a decrease in Defense Logistics Agency (“DLA”) F-16 Structural Wing Components and MRO Services, partly offset by an increase in USAF T-38 Pacer Classic Structural Modification Kits.

Revenue from commercial subcontracts was $1,935,741 for the three months ended March 31, 2023 compared to $1,409,130 for the three months ended March 31, 2022, an increase of $526,610 or 37.4%. The increase was primarily the result of higher revenue recognized on Embraer Phenom Engine Inlet Assemblies, partly offset by lower revenue recognized on the Gulfstream G650 Wing Fixed Leading Edges.

Cost of Sales

Total Cost of Sales for the three months ended March 31, 2023 and 2022 was $17,354,152 and $16,700,488, respectively, an increase of $653,664 or 3.9%.

The components of the cost of sales were as follows:

  Three months ended 
  March 31,
2023
  March 31,
2022
 
Procurement $12,074,601  $11,171,725 
Labor  1,854,863   1,986,268 
Factory overhead  3,779,878   4,267,639 
Other cost of sales  (355,190)  (725,144)
Cost of sales $17,354,152  $16,700,488 

18

Procurement for the three months ended March 31, 2023 was $12,074,601 compared to $11,171,725 for the three months ended March 31, 2022, an increase of $902,876 or 8.1%. The increase was primarily related to increases in Raytheon NGJ Pods and Lockheed Martin RI/DCC Module Assemblies, partly offset by decreases in the Northrop Grumman WOWP’s and Sikorsky HIRRS Module Assemblies.

Labor costs for the three months ended March 31, 2023 were $1,854,863 compared to $1,986,268 for the three months ended March 31, 2022, a decrease of $131,405 or 6.6%. The decrease was primarily related to decreases in Northrop Grumman WOWP’s and Sikorsky HIRRS Module Assemblies.

Factory overhead for the three months ended March 31, 2023 was $3,779,878 compared to $4,267,639 (which included a $134,628 severance charge recorded in factory overhead during the three months ended March 31, 2022) for the three months ended March 31, 2022, a decrease of $487,761 or 11.4%. This decrease was primarily the result of lower salary and benefit costs, factory supplies and delivery charges. Excluding the $134,628 severance charge recorded during the three months ended March 31, 2022, the factory overhead for the three months ended March 31, 2023 decreased $353,133 or 7.8% from the factory overhead for the three months ended March 31, 2022. This decrease was primarily the result of lower salary and benefit costs, factory supplies and delivery charges.

Other cost of sales relates to items that can increase or decrease cost of sales such as changes in inventory levels, changes in inventory valuation, changes to inventory reserves, changes in loss contract provisions, absorption variances and direct charges to cost of sales. For the three months ended March 31, 2023, there was a reduction of these costs in the amount of $355,190 compared to a reduction of these costs in the amount of $725,144 for the three months ended March 31, 2022, a decrease of $369,954 or 51.0%. The decrease is primarily the result of a lower level of loss contract reserve reduction for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022.

Gross Profit

Gross profit and gross profit percentage (“gross margin”) for the three months ended March 31, 2023 was $4,662,516 and 21.2%, respectively, compared to $3,434,609 and 17.1%, respectively, for the three months ended March 31, 2022, an increase of $1,227,907 and 410 basis points, respectively, for the reasons noted above.

Favorable/Unfavorable Adjustments to Gross Profit

During the three months ended March 31, 2023 and 2022, circumstances required that we make changes in estimates to various contracts. Such changes in estimates resulted in changes in total gross profit as follows:

  Three months ended 
  March 31,
2023
  March 31,
2022
 
Favorable adjustments $825,981  $1,277,058 
Unfavorable adjustments  (1,546,986)  (958,997)
Net adjustments $(721,005) $318,062 

For the three months ended March 31, 2023, we evaluated all contractual data and revised estimated gross profit percentages accordingly. We had 23 contracts with favorable adjustments and 31 contracts with unfavorable adjustments, all due to changes in estimates.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2023 were $2,869,058 compared to $3,137,657 (which included a $637,206 severance charge recorded in selling, general and administrative expenses during the three months ended March 31, 2022) for the three months ended March 31, 2022, a decrease of $268,599 or 8.6%. The decrease was primarily the result of lower salary and benefit expenses as well as lower insurance expenses. Excluding the aforementioned $637,206 severance charge as well as $263,148 of restricted stock forfeitures recorded during the three months ended March 31, 2022, the selling, general and administrative expenses for the three months ended March 31, 2023 increased $105,459 or 3.8% from the selling, general and administrative expenses for the three months ended March 31, 2022. This increase was primarily the result of increased salary and benefits partly offset by lower insurance expenses.

Interest expense

Interest expense for the three months ended March 31, 2023 was $610,896, compared to $328,608 for the three months ended March 31, 2022, an increase of $282,288 or 85.9%. The increase was the result of higher year-over-year interest rates charged on our outstanding debt under the Credit FacilityAgreement, partially offset by a year-over-year decrease in the amount of our outstanding debt under the Credit Agreement.

Income (Loss) Before Provision for Income Taxes

Income (Loss) before provision for income taxes for the three months ended March 31, 2023 was $1,182,562 compared to $(31,656) for the three months ended March 31, 2022, an increase of $1,214,218 for the reasons noted above.

Provision for Income Taxes

Provision for income taxes for the three months ended March 31, 2023 was $199,257 compared to $1,275 for the three months ended March 31, 2022, an increase of $197,982. The increase in the provision for income tax is the result of the Company’s valuation allowance on its deferred tax asset being partially released at December 31, 2022, resulting in the change in the deferred asset for the three months ending March 31, 2023 being recorded through the Company’s statement of operations for the three months ending March 31, 2023. For the three months ending March 31, 2022 the company’s deferred tax assets were fully offset by the valuation allowance, therefore there was only minimum state tax income expense recorded to the Company’s statement of operations during the three months ending March 31, 2022.

The effective income tax rate for the three months ended March 31, 2023 is 16.8%. The difference between the effective income tax rate for the three months ended March 31, 2023 and the statutory income tax rate of 21% for the three months ended March 31, 2023 is due to the estimated R&D credit, state income taxes and permanent tax differences.

19

Net Income (Loss) and Earnings (Loss) per Share

Net income (loss) for the three months ended March 31, 2023 of $983,305 or $0.08 per basic and diluted share, compared to $(32,931) or $(0.00) for the three months ended March 31, 2022, an increase of $1,016,236 for the reasons noted above. Basic and diluted income per share for the three months ended March 31, 2023 was calculated using 12,520,189 and 12,608,189 weighted average basic and diluted shares outstanding, respectively. Basic and diluted (loss) per share for the three months ended March 31, 2022 was calculated using 12,363,143 weighted average basic and diluted shares outstanding.

Excluding the $771,834 severance charge recorded in the first quarter of 2022 as referred to above under Cost of Sales and Selling, General and Administrative Expenses, net income for the three months ended March 31, 2023 increased $244,402 or 33.1% from net income for the three months ended March 31, 2022.

Excluding the aforementioned severance charge, basic and diluted earnings per share for the three months ended March 31, 2023 increased $0.02 or 33.3% from basic and diluted earnings per share for the three months ended March 31, 2022.

20

Liquidity and Capital Resources

General

At March 31, 2023, we had working capital of $13,736,671 compared to $12,896,602 at December 31, 2022, an increase of $840,069 or 6.5%. This increase was primarily the result of an increase in contract assets and accounts receivable and a decrease in accrued expenses, partly offset by an increase in contract liabilities and accounts payable.

Cash Flow

A large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process and which do not provide for progress payments. Costs and related earnings for which we do not bill on a progress basis, and which, as a result, we bill upon shipment of products, are components of contract assets on our consolidated balance sheets and represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.

Because ASC 606 requires us to use estimates in determining revenue, costs and profits and in assigning the amounts to accounting periods, there can be a significant disparity between earnings (both for accounting and tax purposes) as reported and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash flow and may need to borrow money or take steps to defer cash outflows until the reported earnings materialize into actual cash receipts.

Some of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In the case of significant program delays and/or program cancellations, we could experience margin degradation, which may be material for costs that are not recoverable. Such charges and the loss of up-front costs could have a material impact on our liquidity and results of operations.

We continuously work to improve our payment terms from our customers, including accelerated progress payment arrangements, as well as exploring alternate funding sources.

At March 31, 2023, we had cash of $3,997,924 compared to $3,847,225 at December 31, 2022, an increase of $150,699 or 3.9%. This increase was primarily the result of cash flow from operations, partly offset by repayment of long-term debt and debt issuance costs.

Bank Credit Facilities

 

On April 12, 2022March 24, 2016, the Company entered into an Amended and Restated Credit Agreement with the Ninthlenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The Credit Agreement originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate as defined in the Credit Agreement.

On March 23, 2023, the Company entered into a Twelfth Amendment (defined below) to the Credit Agreement (defined below)(the “Twelfth Amendment”). Under the NinthTwelfth Amendment, the parties amended the Credit Agreement by : (a) extending the maturity date of the Revolving LoanCompany’s existing revolving line of credit and its existing term loan to November 30, 2024 (under the Term Loan to September 30, 2023, (b) providing for the repayment of an additional $750,000terms of the Credit Agreement, the outstanding principal balance of the Term Loan in three installmentsterm loan will be repaid by June 30, 2023); (b) providing for reduction of $250,000 on September 30, 2022, December 31, 2022 and March 31,the aggregate maximum principal amount of all revolving line of credit loans to $20,520,000 from October 1, 2023 in addition to $200,000 regular monthly principal payments through December 31, 20222023, $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, and $17,640,000 from October 1, 2024 and thereafter, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period; and (c) increasing the interest on the Revolving Loan, Term Loan, and the Amendment Fee (defined below) provided forpayment of a $250,000 capitalized fee incurred in connection with the Eighth Amendment (defined below) as follows: through June 30, 2022, Prime Rate (as defined in the Credit Agreement) plus 2.5%; from July 1, 2022 through August 31, 2022, Prime Rate plus 5%; from September 1, 2022 through October 31, 2022, Prime Rate plus 6%; from November 1, 2022 through December 31, 2022, Prime Rate plus 7%; and from January 1, 2023 through September 30, 2023, Prime Rate plus 8%. Additionally, under the Ninth Amendment,to the Credit Agreement, financial covenants were amended. BankUnited also waived or consented to certain covenant non-compliance, waived temporarily or consented to, late delivery of certain financial information and waived permanently late delivery of certain pro-forma budget information.

On August 19, 2022, we entered into the Tenth Amendment (defined below). Under the Tenth Amendment, the parties amended the Credit Agreement by (a) increasing the maximum leverage ratio applicable for the fiscal quarter ending September 30, 2022 to 5.0, (b) waiving and/or consenting to the exclusion from the Company’s covenant compliance requirements for the fiscal quarters ended December 31, 2021, March 31, 2022, June 30, 2022 and September 30, 2022 up to (i) $566,024.81 of losses incurred and reserves taken under the Borrower’s welded product contracts, and (ii) $367,044.51 of reserves taken with respect to the Borrower’s welded product inventory, and (c) waiving and/or consenting to the exclusion from the Company’s covenant compliance requirements for the fiscal quarters ended March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022 up to $795,997.06 of accrued severance and COBRA costs and employer taxes incurred by the Company during the fiscal quarter ending March 31, 2022. Additionally, under the Tenth Amendment, BankUnited waived or consented to late delivery of certain financial information required by the Credit Agreement.

On November 10, 2022,which the Company entered into on October 28, 2021 (the “Eighth Amendment”) in two installments, the Eleventh Amendment(defined below). Underfirst installment to be paid on June 1, 2023 in the Eleventh Amendment, the parties amended the Credit Agreement by (a) extending the maturity dateamount of the Revolving Loan$116,667 and the Term Loansecond installment to November 30,be paid July 1, 2023 orin the amount of $133,333, together with respect toall unpaid interest accrued at the Term Loan, if earlier, until the outstanding principal balance is paid in full (the “Term Loan Maturity Date”), (b) providing for regular monthly principal payments of $200,000term loan interest rate on the Term Loan from January 1, 2023capitalized fee through the Term Loan Maturity Date (in addition to the Company’s existing obligation to make two principal payments on the Term Loan of $250,000 on each of December 31, 2022 and March 31, 2023) and (c) decreasing the interest on the Revolving Loan, the Term Loan and the Amendment Fee to the Prime Rate plus 3.5%, effective as of November 1, 2022.such date.

21

 

The Credit Agreement, as amended, requires us to maintain the following financial covenants (subject to the exclusions provided for in the previous paragraph): (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for the trailing four quarter period ended March 31, 2022, 0.95 to 1.0 for the trailing four quarter period ended June 30, 2022, and 1.5 to 1.0 for the trailing four quarter period ended September 30, 2022 and for the trailing four quarter periods ended thereafter; (b) maximum leverage ratio of no less than 7.30 to 1.0 for the trailing four quarter period ended March 31, 2022, 6.30 to 1.0 for the trailing four quarter period ended June 30, 2022, 5.0 to 1.0 for the trailing four quarter period ended September 30, 2022 and 4.0 to 1 for the trailing four quarter periods thereafter; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00 commencing June 30, 2022; and (d) a minimum adjusted EBITDA at the end of each quarter of no less than $1.0 million (waived for the quarter ended March 31, 2022). The additional principal payments, increase in interest and the Amendment Fee provided for in the Eight Amendment and Ninth Amendment are excluded for purposes of calculating compliance with each of the financial covenants.

Settlement of Class Action

As previously disclosed, a consolidated class action lawsuit has been filed against the Company, Douglas McCrosson, the Company’s former Chief Executive Officer, Vincent Palazzolo, the Company’s former Chief Financial Officer, and the two underwriters of the Company’s October 16, 2018 offering of common stock, Canaccord Genuity LLC and B. Riley FBR. The Amended Complaint in the action asserts claims on behalf of two plaintiff classes: (i) purchasers of the Company’s common stock issued pursuant to and/or traceable to the Company’s offering conducted on or about October 16, 2018; and (ii) purchasers of the Company’s common stock between March 22, 2018 and February 14, 2020. The Amended Complaint alleges that the defendants violated Sections 11, 12(a)(2), and 15 of the Securities Act by negligently permitting false and misleading statements to be included in the registration statement and prospectus supplements issued in connection with its October 16, 2018 securities offering. The Amended Complaint also alleges that the defendants violated Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 promulgated by the SEC, by making false and misleading statements in the Company’s periodic reports filed between March 22, 2018 and February 14, 2020. Plaintiff seeks unspecified compensatory damages, including interest; rescission or a rescissory measure of damages; unspecified equitable or injunctive relief; and costs and expenses, including attorney’s fees and expert fees. On February 19, 2021, the Company moved to dismiss the Amended Complaint. Plaintiff submitted a brief in opposition to the motion to dismiss on April 23, 2021.

15

On May 20, 2021, the parties reached a settlement in the amount of $3,600,000, subject to court approval. On July 9, 2021, Plaintiff filed an unopposed motion for preliminary approval of the settlement. On November 10, 2021, a magistrate judge recommended that the Court grant the motion for preliminary approval in its entirety. The Court adopted the recommendation on May 27, 2022, and entered an order granting preliminary approval of the settlement on June 7, 2022. On August 5, 2022, the Plaintiff filed an unopposed motion for final approval. The magistrate judge held a hearing on September 9, 2022, and is now deciding whether to grant final approval of the settlement. After satisfaction of our $750,000 retention, the Settlement Amount will be covered and paid by our directors’ and officers’ insurance carrier. As of September 30, 2022, we have previously paid and accrued to our financial statements covered expenses totaling $750,000, and have therefore met our directors’ and officers’ retention requirement,Credit Agreement, which caps the Company’s expenses pertaining to the class action suit.

At September 30, 2022, in order to reflect the amounts owed from our directors’ and officers’ insurance carrier and to the Plaintiffs, we have recorded to our balance sheet a litigation settlement obligation of $3,600,000 and an insurance recovery receivable of $3,600,000 to reflect the liability owed by the Company to the Plaintiffs as well as the amount receivable owing from the Company’s insurance carrier to the Company with respect to the settlement obligation.

Backlog

We produce custom assemblies pursuant to long-term contracts and customer purchase orders. Funded backlog consists of aggregate funded values under such contracts and purchase orders, excluding the portion previously included in operating revenues pursuant to Accounting Standards Codification Topic 606 (“ASC 606”). Unfunded backlog is the estimated amount of future orders under the expected duration of the programs. Substantially all of our backlog is subject to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore, our funded backlog does not include the full value of our contracts.

Our total backlog as of September 30, 2022 and December 31, 2021 was as follows:

Backlog
(Total)
 September 30,
2022
  December 31,
2021
 
Funded $118,135,000  $134,722,000 
Unfunded  382,757,000   366,997,000 
Total $500,892,000  $501,719,000 

Approximately 98% of the total amount of our backlog at September 30, 2022 was attributable to government contracts. Our backlog attributable to government contracts at September 30, 2022 and December 31, 2021 was as follows:

Backlog
(Government)
 September 30,
2022
  December 31,
2021
 
Funded $115,358,000  $132,499,000 
Unfunded  375,342,000   358,133,000 
Total $490,700,000  $ 490,632,000 

Our backlog attributable to commercial contracts at September 30, 2022 and December 31, 2021 was as follows:

Backlog
(Commercial)
 September 30,
2022
  December 31,
2021
 
Funded $2,777,000  $2,223,000 
Unfunded  7,415,000   8,864,000 
Total $10,192,000  $11,087,000 

The total backlog at September 30, 2022 is primarily comprised of long-term programs with Raytheon (Next Generation Jammer – Mid Band Pod), Raytheon (Advanced Tactical Pod), USAF (T-38), Boeing (A-10 Main Landing Gear Pod), Lockheed Martin F-16 RI/DCC, Raytheon (B-52 Radar Rack), Collins Aerospace (MS-110 Pod), Sikorsky UH-60 Gunner Window, Stabilator MRO and IR Module Assembly (HIRSS) and Embraer Phenom 300 Inlets. Funded backlog is primarily from purchase orders under long-term contracts with USAF (T-38), Boeing (A-10 Main Landing Gear Pod), Raytheon (Next Generation Jammer – Mid Band Pod), Northrop Grumman (E-2D), Lockheed Martin F-16 Rudder Island and Sikorsky IR Module Assembly (HIRSS).

Critical Accounting Policies

We make a number of significant estimates, assumptions and judgments in the preparation of our financial statements. See Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Form 10-K, for a discussion of our critical accounting policies. There have been no significant changes to the application of our critical accounting policies during the quarter ended September 30, 2022.

Results of Operations

Revenue

Total Revenue for the three months ended September 30, 2022 was $20,196,913 compared to $23,898,748 for the same period last year, a decrease of $3,701,835 or 15.5%. The decrease was primarily related to decreases in revenue from the Northrop Grumman E2D MYP II.

16

Total Revenue for the nine months ended September 30, 2022 was $59,257,416 compared to $77,018,684 for the same period last year, a decrease of $17,761,268 or 23.1%. The decrease was primarily related to decreases in the Raytheon NGJ MB Pods, Northrop Grumman E2D MYP II and Northrop Grumman E2D WOWP programs partly offset by increases in the Sikorsky HIRRS and the Raytheon NGJ Mid-band LRIP programs.

Revenue from government subcontracts was $17,213,747 for the three months ended September 30, 2022 compared to $21,873,152 for the three months ended September 30, 2021, a decrease of $4,659,405 or 21.3%. The decrease was primarily to decreases in the Northrop Grumman E2D MYP II, the Northrop Grumman E2D WOWP, the Sikorsky Weapons Pylon and the Raytheon Missile Wings programs partly offset by an increase in the Raytheon NGJ MB Pods program.

Revenue from government subcontracts was $49,930,578 for the nine months ended September 30, 2022 compared to $70,167,598 for the nine months ended September 30, 2021, a decrease of $20,237,020 or 28.8%. The decrease was primarily related to decreases in the Raytheon NGJ MB Pods, the Northrop Grumman E2D OWP MYP II and Northrop Grumman E2D WOWP, partly offset by increases in the Sikorsky HIRRS program.

Revenue from direct military contracts was $1,660,913 for the three months ended September 30, 2022 compared to $922,443 for the three months ended September 30, 2021, an increase of $738,470 or 80.1%. The increase is primarily related to an increase in the T-38 Pacer Classic program.

Revenue from direct military contracts was $5,077,459 for the nine months ended September 30, 2022 compared to $2,820,981 for the nine months ended September 30, 2021, an increase of $2,256,478 of 80.0%. The increase revenue is primarily related to an increase in the T-38 Pacer Classic program.

Revenue from commercial subcontracts was $1,322,253 for the three months ended September 30, 2022 compared to $1,103,153 for the three months ended September 30, 2021, an increase of $219,100 or 19.9%. The increase is primarily related to an increase in the Embraer Inlets program, partly offset by a decrease in the Gulfstream G650 program.

Revenue from commercial subcontracts was $4,249,379 for the nine months ended September 30, 2022 compared to $4,030,104 for the nine months ended September 30, 2021, an increase of $219,275 or 5.4%. The increase is primarily the result of an increase in the Embraer Inlets program, partly offset by decrease in the Gulfstream G650 program and the Sikorsky S-92 Kits program.

Cost of Sales

Total Cost of Sales for the three months ended September 30, 2022 and 2021 was $14,869,100 and $20,246,764, respectively, a decrease of $5,377,664 or 26.6%. This decrease is the result of the comparable decrease in revenue and the specific program related factors noted below.

Total Cost of Sales for the nine months ended September 30, 2022 and 2021 was $46,835,304 and $64,850,010, respectively, a decrease of $18,014,706 or 27.8%. This decrease is the result of the comparable decrease in revenue and the specific program related factors noted below.

The components of the cost of sales were as follows:

  Three months ended  Nine months ended 
  September 30,
2022
  September 30,
2021
  September 30,
2022
  September 30,
2021
 
Procurement $9,867,224  $14,373,181  $31,455,680  $47,709,154 
Labor  1,561,910   2,055,353   5,255,245   5,945,219 
Factory overhead  3,785,304   4,860,469   11,794,369   14,934,140 
Other cost of sales  (345,338)  (1,042,239)  (1,669,990)  (3,738,503)
Cost of sales $14,869,100  $20,246,764  $46,835,304  $64,850,010 

Procurement for the three months ended September 30, 2022 was $9,867,224 compared to $14,373,181 for the three months ended September 30, 2021, a decrease of $4,505,957 or 31.3%. This decrease is primarily related to decreases in the Northrop Grumman E2D MYP II, Raytheon NGJ MB Pods and Northrop Grumman E2D WOWP programs.

Procurement for the nine months ended September 30, 2022 was $31,455,680 compared to $47,709,154 for the nine months ended September 30, 2021, a decrease of $16,253,474 or 34.1%. This decrease is primarily related to decreases in the Northrop Grumman E2D MYP II, Raytheon NGJ MB Pods and Northrop Grumman E2D WOWP programs.

Labor costs for the three months ended September 30, 2022 were $1,561,910 compared to $2,055,353 for the three months ended September 30, 2021, a decrease of $493,443 or 24%. This decrease is primarily related to decreases in the Raytheon NGJ MB Pods program.

Labor costs for the nine months ended September 30, 2022 were $5,255,245 compared to $5,945,219 for the nine months ended September 30, 2021, a decrease of $689,974 or 11.6%. This decrease is primarily related to decreases in the Raytheon NGJ MB Pods program.

Factory overhead for the three months ended September 30, 2022 was $3,785,304 compared to $4,860,469 for the three months ended September 30, 2021, a decrease of $1,075,165 or 22.1%. This decrease is primarily the result of lower salary and benefit costs.

Factory overhead for the nine months ended September 30, 2022 was $11,794,369 compared to $14,934,140 for the nine months ended September 30, 2021, a decrease of $3,139,771 or 21.0%. This decrease is primarily the result of lower salary and benefit costs, partially offset by a $134,628 severance charge recorded in the first quarter of 2022.

17

Other cost of sales relates to items that can increase or decrease cost of sales such as changes in inventory levels, changes in inventory valuation, changes to inventory reserves, changes in loss contract provisions, absorption variances and direct charges to cost of sales. Other costs (credit), net for the three months ended September 30, 2022 were $(345,338) compared to $(1,042,239) for the three months ended September 30, 2021, a decrease of the credit of $696,901, or 66.9%. The change in the three months ended September 30, 2022 is primarily due to changes in inventory levels, reductions in the inventory reserves and reductions in the loss reserve.

Other costs (credit), net for the nine months ended September 30, 2022 were $(1,669,990) compared to $(3,738,503) for the nine months ended September 30, 2021, a decrease of the credit of $2,068,513, or 55.3%. The change in the nine months ended September 30, 2022 is primarily due to changes in inventory levels, reductions in the inventory reserves and reductions in the loss reserve.

Gross Profit

Gross profit for the three months ended September 30, 2022 was $5,327,813 compared to $3,651,984 for the three months ended September 30, 2021, an increase of $1,675,829, or 45.9% for the reasons noted above. Gross profit percentage (“gross margin”) for the three months ended September 30, 2022 was 26.4% compared to 15.3% for three months ended September 30, 2021. The increase in gross margin was primarily due to a favorable job mix and operating efficiencies during the three months ended September 30, 2022 as compared to the three months ended September 30, 2021.

Gross profit for the nine months ended September 30, 2022 was $12,422,112 compared to $12,168,674 for the nine months ended September 30, 2021, an increase of $253,438, or 2.1% for the reasons noted above. Gross profit percentage (“gross margin”) for the nine months ended September 30, 2022 was 21.0% compared to 15.8% for the nine months ended September 30, 2021. The increase in gross margin was primarily due to a favorable job mix and operating efficiencies during the nine months ended September 30, 2022 as compared to the nine months ended September 30, 2021.

Favorable (Unfavorable) Adjustments to Gross Profit

During the nine months ended September 30, 2022 and 2021, circumstances required that we make changes in estimates to various contracts. Such changes in estimates resulted in changes in total gross profit as follows:

  Nine months ended 
  September 30,
2022
  September 30,
2021
 
Favorable adjustments $4,710,232  $3,116,037 
Unfavorable adjustments  (2,646,510)  (3,366,056)
Net adjustments $2,063,721  $(250,019)

For the nine months ended September 30, 2022, we evaluated all contractual data and revised estimated gross profit percentages accordingly. We had 29 contracts with favorable adjustments and 24 contracts with unfavorable adjustments, all due to changes in estimates.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended September 30, 2022 were $2,744,265 compared to $2,765,849 for the three months ended September 30, 2021, a decrease of $21,584 or 0.8%.

Selling, general and administrative expenses for the nine months ended September 30, 2022 were $8,579,314 compared to $8,834,343 for the nine months ended September 30, 2022, a decrease of $255,029 or 2.9%. This decrease was primarily driven by lower legal fees, partly offset by increases in insurance expenses and higher salaries expense as a result of a $637,206 severance charge recorded in the first quarter of 2022.

Income Before Provision for Income Taxes

Income before provision for income taxes for the three months ended September 30, 2022 was $1,862,502 compared to $5,428,629 for the same period last year, a decrease of $3,566,127 or 65.7% for the reasons noted above.

Income before provision for income taxes for the nine months ended September 30, 2022 was $2,354,707 compared to $7,288,651 for the same period last year, a decrease of $4,933,944 or 67.7% for the reasons noted above.

Provision for Income Taxes

Provision for income taxes was $3,750 for the three months ended September 30, 2022, compared to a provision for income taxes of $3,374 for the three months ended September 30, 2021, an increase of $376 or 11.1%.

Provision for income taxes was $11,250 the nine months ended September 30, 2022, compared to a provision for income taxes of $7,702 for the nine months ended September 30, 2021, an increase of $3,548 or 46.1%.

Net Income

Net income for the three months ended September 30, 2022 was $1,858,752 or $0.15 per basic share, compared to net income of $5,425,255 or $0.44 per basic share for the same period last year. Diluted income per share was $0.15 for the three months ended September 30, 2022 calculated utilizing 12,349,283 weighted average shares outstanding versus diluted income per share of $0.44 for the same period last year calculated utilizing 12,320,588 weighted average shares outstanding.

Net income for the nine months ended September 30, 2022 was $2,343,457 or $0.19 per basic share, compared to net income of $7,820,949 or $0.60 per basic share for the same period last year. Diluted income per share was $0.19 for the nine months ended September 30, 2022 calculated utilizing 12,410,491 weighted average shares outstanding versus diluted income per share of $0.60 for the same period last year calculated utilizing 12,187,714 weighted average shares outstanding.

Excluding the $771,834 severance charge recorded in the first quarter of 2022 as referred to above under Cost of Sales and Selling, General and Administrative Expenses, our net income for the nine months ended September 30, 2022 was $3,115,291, a decrease over the prior year of $4,705,658 or 60.2%. Excluding the aforementioned severance charge, our basic and diluted earnings per share was $0.25 for the nine months ended September 30, 2022 as compared to the $0.60 income per basic and diluted share for the nine months ended September 30, 2021.

18

Liquidity and Capital Resources

General

At September 30, 2022, we had working capital of $13,618,489 compared to working capital of $12,175,776 at December 31, 2021, an increase of $1,442,713 or 11.8%.

Cash Flow

A large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process and which do not provide for progress payments. Costs for which we are not able to bill on a progress basis are components of “Contract Assets” on our consolidated balance sheets and represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.

Because ASC 606 requires us to use estimates in determining revenue, costs and profits and in assigning the amounts to accounting periods, there can be a significant disparity between earnings (both for accounting and tax purposes) as reported and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash flow and may need to borrow money, or to raise additional capital, until the reported earnings materialize into actual cash receipts.

Several of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In the case of significant program delays and/or program cancellations, we could be required to bear impairment charges, which may be material for costs that are not recoverable. Such charges and the loss of up-front costs could have a material impact on our liquidity and results of operations.

We continue to work to obtain better payment terms with our customers, including accelerated progress payment arrangements, as well as exploring alternate funding sources.

At September 30, 2022, we had a cash balance of $4,627,379 compared to $6,308,866 at December 31, 2021, a decrease of $1,681,487, or 26.7%. The decrease was comprised of $2,463,625 in debt paydowns and $25,317 in purchase of property and equipment, partly offset by cash provided by operating activities of $807,455.

Bank Credit Facilities

On March 24, 2016, the Company entered into an Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The Credit Agreement originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate as defined in the Credit Agreement.

On May 11, 2021, the Company entered into a Waiver and Seventh Amendment to the Credit Agreement (the “Seventh Amendment”). Under the Seventh Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the $24 million Revolving Loan and $6.36 million Term Loan to July 31, 2022, and (b) amending the leverage ratio covenant for the fiscal quarters ending on and after March 31, 2021, to 4.0 to 1.0, determined at the end of each fiscal quarter for the trailing four-quarter period then ended (or, in the case of the fiscal quarter ended March 31, 2021, determined on an annualized basis for the three-quarter period then ended). Additionally, under the Seventh Amendment, BankUnited waived late delivery of certain financial information.

On October 28, 2021, the Company entered into a Waiver and Eighth Amendment to the Credit Agreement (the “Eighth Amendment”). Under the Eighth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Revolving Loan and the Term Loan to December 31, 2022, (b) reducing the aggregate revolving line of credit from $24 million to $21 million while eliminating the requirement to maintain a minimum $3.0 million in a combination of line of credit availability and unrestricted cash, (c) providing for the repayment of an additional $750,000 of the principal balance of the term loan in three installments of $250,000 on November 30, 2021, December 31, 2021 and March 31, 2022 in addition to $200,000 regular monthly principal payments through maturity, (d) amending the minimum debt service coverage ratio covenant for the fiscal quarters ending on and after June 30, 2021 to provide for a ratio of 1.5 to 1.0, and (e) amending the maximum leverage ratio covenant as follows: for the fiscal quarter ending on March 31, 2021 - 5.0 to 1.0; for the fiscal quarter ending June 30, 2021 - 4.75 to 1.0; for the fiscal quarter ending September 30, 2021 - 4.25 to 1.0 and for the fiscal quarter ended December 31, 2021 and thereafter - 4.0 to 1.0, determined at the end of each fiscal quarter for the trailing four-quarter period then ended (or, in the case of the fiscal quarter ended March 31, 2021, determined on an annualized basis for the three-quarter period then ended). Additionally, under the Eighth Amendment, BankUnited waived certain covenant non-compliance and waived temporarily, late delivery of certain financial information. In connection with the Eighth Amendment, a $250,000 amendment fee (the “Amendment Fee”) was earned by the lenders on December 31, 2021 which the Company elected to pay in kind and accrue and capitalize rather than pay in cash. As at December 31, 2021, the Amendment Fee payable was posted by BankUnited to the Revolving Loan and on February 11, 2022, in agreement with the Company, the Amendment Fee was reclassified by BankUnited to the Term Loan. The Company has recorded this payable to its financial statements accordingly.

On April 12, 2022 the Company entered into a Consent, Waiver and Ninth Amendment (the “Ninth Amendment”) to the Credit Agreement. Under the Ninth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Revolving Loan and the Term Loan to September 30, 2023, (b) providing for the repayment of an additional $750,000 of the principal balance of the Term Loan in three installments of $250,000 on September 30, 2022, December 31, 2022 and March 31, 2023 in addition to $200,000 regular monthly principal payments through December 31, 2022 and (c) increasing the interest on the Revolving Loan, Term Loan, and the Amendment Fee as follows: through June 30, 2022, Prime Rate (as defined in the Credit Agreement) plus 2.5%; from July 1, 2022 through August 31, 2022, Prime Rate plus 5%; from September 1, 2022 through October 31, 2022, Prime Rate plus 6%; from November 1, 2022 through December 31, 2022, Prime Rate plus 7%; and from January 1, 2023 through September 30, 2023, Prime Rate plus 8%. Additionally, under the Ninth Amendment, the Credit Agreement financial covenants were amended. BankUnited also waived or consented to certain covenant non-compliance, waived temporarily or consented to, late delivery of certain financial information and waived permanently late delivery of certain pro-forma budget information.

On August 19, 2022, we entered into a Consent, Waiver and Tenth Amendment to the Credit Agreement (the “Tenth Amendment”). Under the Tenth Amendment, the parties amended the Credit Agreement by (a) increasing the maximum leverage ratio applicable for the fiscal quarter ending September 30, 2022 to 5.0, (b) waiving and/or consenting to the exclusion from the Company’s covenant compliance requirements for the fiscal quarters ended December 31, 2021, March 31, 2022, June 30, 2022 and September 30, 2022 up to (i) $566,024.81 of losses incurred and reserves taken under the Borrower’s welded product contracts, and (ii) $367,044.51 of reserves taken with respect to the Borrower’s welded product inventory, and (c) waiving and/or consenting to the exclusion from the Company’s covenant compliance requirements for the fiscal quarters ended March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022 up to $795,997.06 of accrued severance and COBRA costs and employer taxes incurred by the Company during the fiscal quarter ending March 31, 2022. Additionally, under the Tenth Amendment, BankUnited waived or consented to late delivery of certain financial information required by the Credit Agreement.

On November 10, 2022, the Company entered into an Eleventh Amendment to the Credit Agreement (the “Eleventh Amendment”). Under the Eleventh Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Revolving Loan and the Term Loan to November 30, 2023 or with respect to the Term Loan, if earlier, until the outstanding principal balance is paid in full (the “Term Loan Maturity Date”), (b) providing for regular monthly principal payments of $200,000 on the Term Loan from January 1, 2023 through the Term Loan Maturity Date (in addition to the Company’s existing obligation to make two principal payments on the term loan of $250,000 on each of December 31, 2022 and March 31, 2023) and (c) decreasing the interest on the Revolving Loan, the Term Loan and the Amendment Fee to the Prime Rate plus 3.5%, effective as of November 1, 2022.

19

The Credit Agreement, as amended, requires us to maintain the following financial covenants (subject to the exclusions provided for in the previous paragraph): (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for the trailing four quarter period ended March 31, 2022, 0.95 to 1.0 for the trailing four quarter period ended June 30, 2022, and 1.5 to 1.0 for the trailing four quarter period ended September 30, 2022 and for the trailing four quarter periods ended thereafter; (b) maximum leverage ratio of no less than 7.30 to 1.0 for the trailing four quarter period ended March 31, 2022, 6.30 to 1.0 for the trailing four quarter period ended June 30, 2022, 5.0 to 1.0 for the trailing four quarter period ended September 30, 2022 and 4.0 to 1 for the trailing four quarter periods thereafter; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00 commencing June 30, 2022; and (d) a minimum adjusted EBITDA at the end of each quarter of no less than $1.0 million (waived for the quarter ended March 31, 2022). The additional principal payments, increase in interest and the Amendment Fee provided for in the Eight Amendment and Ninth Amendment are excluded for purposes of calculating compliance with each of the financial covenants.

 

The BankUnited Facility is secured by all of the Company’s assets and both the Revolving Loan and Term Loan borebear interest at the rate of 12.25% (the Prime Rate of 6.25% + 6.00%)3.50%. The Prime Rate was 8.00% as of September 30, 2022.March 31, 2023 and as such, the Company’s interest rate on both the Revolving Loan and Term Loan was 11.50% as of March 31, 2023.

 

As of September 30,March 31, 2023 and December 31, 2022, the Company had $21,000,000 outstanding under the Revolving Loan as compared to $21,250,000 as of December 31, 2021.Loan.

 

TheAs of March 31, 2023, the Term Loan, as amended by the EleventhTwelfth Amendment, had an aggregate principal amount of $2,433,333,$983,333, payable in monthly installments, as defined in the agreement, as of September 30, 2022Twelfth Amendment, as compared to an aggregate principal amount outstanding as of December 31, 20212022 of $4,483,333.$1,583,333.

 

There is currently no availability for borrowings under the Revolving Loan and the Company finances its operations from internally generated cash flow.

 

PPP Loan

On April 10, 2020, we entered into the PPP Loan with Dime as the Lender, in an aggregate principal amount of $4,795,000, pursuant to the Paycheck Protection Program under the CARES Act. The PPP Loan was evidenced by a promissory note (“Note”). Subject to the terms of the Note, the PPP Loan bore interest at a fixed rate of one percent (1%) per annum, with the first six months of interest deferred, had an initial term of two years, and was unsecured and guaranteed by the SBA. The Note provided for customary events of default including, among other things, cross-defaults on any other loan with the Lender. The PPP Loan could have been accelerated upon the occurrence of an event of default.

On November 2, 2020, the Company applied to the Lender for full forgiveness of the PPP Loan as calculated in accordance with the terms of the CARES Act, as modified by the Paycheck Protection Flexibility Act. On July 13, 2021, the Company received notification through Dime that the PPP Loan and accrued interest thereon had been fully forgiven by the SBA and that the forgiveness payment date was July 1, 2021. The forgiveness of the PPP Loan was recognized during the Company’s third fiscal quarter ending September 30, 2021.

Liquidity

 

We believe that our existing resources as of September 30, 2022March 31, 2023 will be sufficient to meet our current working capital needs for at least the next 12 months from the date of issuance of our consolidated financial statements. However, our working capital requirements can vary significantly, depending in part on the timing of new program awards and the payment terms with our customers and suppliers. If our working capital needs exceed our cash flows from operations, we would look to our cash balances and availability for borrowings under our borrowing arrangement to satisfy those needs, as well as potential sources of additional capital, which may not be available on satisfactory terms and in adequate amounts, if at all.

 

Contractual Obligations

 

For information concerning our contractual obligations, see Contractual Obligations under Item 7 of Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2021.2022.

 

Inflation

Inflation historically has not had a material effect on our operations, although the current inflationary environment in the U.S., and its impact on interest rates, the supply chain, the labor market and general economic conditions, are factors that the Company actively monitors in an attempt to mitigate and manage potential negative impacts on and risks faced by the Company. The majority of the Company’s long term contracts with its customers reflect fixed pricing and its long term contracts with its suppliers reflect fixed pricing. When bidding for work, the Company takes inflation risk and supply side pricing risk into account in its proposals.

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

Item 4 – Controls and Procedures

 

Evaluation of DisclosureItem 4 – Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures, as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of such date, our disclosure controls and procedures were not effective due to the material weaknesses described below.

 

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:

 

 pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our consolidated financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

20

Management conducted an evaluation of the effectiveness of internal control over financial reporting for the twelve months ended December 31, 2022 based on criteria established in Internal Control- Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In connection with this evaluation, of the Company’s internal control over financial reporting, management identified deficiencies that constituted a material weaknessweaknesses in our internal control over financial reporting as of December 31, 2021.2022. For more information on these deficiencies, see Item 9A. Controls and Procedures, included in our Annual Report on Form 10-K.

22

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

 

During 2021,2023, the Company did, and during 2022, intends to continue to implement new controls designed to remediate the aforementioned 20212022 material weaknesses.

 

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2022March 31, 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

23

Part II - Other Information

Item 1 – Legal Proceedings

 

See Footnote 12Item 1Commitments and Contingencies.Legal Proceedings

 

Reference is made to Note 12 entitled “Commitments and Contingencies” to our unaudited condensed consolidated financial statements included in this Quarterly Report for a discussion of current legal proceedings, which discussion is incorporated herein by reference.

Item 1A – Risk Factors

Item 1A – Risk Factors

 

“Item 1A. Risk Factors” of our Form 10-K for the year ended December 31, 2021,2022, includes a discussion of significant factors known to us that could materially adversely affect our business, financial condition, or results of operations. There have been no material changes from the risk factors disclosed in the Annual Report.

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

Item 3 – Defaults Upon Senior Securities

Item 3 – Defaults Upon Senior Securities

 

None.

Item 4 – Mine Safety Disclosures

Item 4 – Mine Safety Disclosures

 

Not applicable.

Item 5 – Other Information

Item 5 – Other Information

 

None.

 

24

Item 6 – Exhibits

Item 6 – Exhibits

 

Exhibit No.

Description

  
10.1Consent, Waiver and TenthTwelfth Amendment to the Amended and Restated Credit Agreement (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 19, 2022)March 23, 2023).
10.231.1*Eleventh Amendment to Amended and Restated Credit Agreement (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 10, 2022).
31.1*Section 302 Certification by Chief Executive Officer and President
31.2*
31.2*Section 302 Certification by Chief Financial Officer (Principal Accounting Officer)
32.1**Section 906 Certification by Chief Executive Officer and Chief Financial Officer
101.INS**Inline XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104**Cover Page Interactive Data File. The cover page XBRL tags are embedded within the Inline XBRL document.

 

* Filed herewith

** Furnished herewith

 

Attached as Exhibit 101 to this report are the following formatted in Inline XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statement of Operations for the three and nine months ended September 30,March 31, 2023 and 2022, and 2021 (ii) Condensed Consolidated Balance Sheet as of September 30, 2022March 31, 2023 and December 31, 2021,2022, (iii) Condensed Consolidated Statement of Cash Flows for the ninethree months ended September 30,March 31, 2023 and 2022, and 2021, (iv) Condensed Consolidated Statement of Changes in Shareholders’ DeficitEquity for the three and nine months ended September 30,March 31, 2023 and 2022 and 2021 and (v) Notes to Condensed Consolidated Financial Statements.

 

2125

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 CPI AEROSTRUCTURES, INC.
   
Dated: November 21, 2022May 15, 2023By./s/ Dorith Hakim
  Dorith Hakim
  

Chief Executive Officer and President

(Principal Executive Officer)

   
Dated: November 21, 2022May 15, 2023By./s/ Andrew L. Davis
  Andrew L. Davis
  

Chief Financial Officer

(Principal Financial and Accounting Officer)

26